<?xml version="1.0" encoding="UTF-8"?>
<html
        >
<head>
    <link rel="stylesheet" href="../../../notes_js/css/sample.css"/>
    <script src="../../../notes_js/jquery-1.8.3.js"></script>
    <script src="../../../notes_js/jpntext.js"></script>
    <script src="../../../notes_js/rangy-core.js"></script>
    <script src="../../../notes_js/rangy-serializer.js"></script>
    <script src="../../../notes_js/android.selection.js"></script>
    <script src="../../../notes_js/search.js"></script>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"></meta>
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1"></meta>
    <title>JAT V45</title>
    <link rel="stylesheet" href="../../css/style.css" type="text/css"></link>
</head>
<body id="content-body" class="green">
<div id="article_header" class="article_header">
    <div id="article_title" class="article_title">Obesity, inflammation, and the gut microbiota
    </div>
    <div id="author-group" class="author-group">
        <div id="authors" class="authors">Dr Amanda J Cox, PhD <sup>a</sup> <sup>b</sup>
            <sup>c</sup> <sup>*</sup><a class="ja50-ce-e-address"
                                        href="mailto:a.cox@griffith.edu.au"><img border="0"
                                                                                 src="image/article_email.png"
                                                                                 alt="a.cox@griffith.edu.au"></img></a>,
            Nicholas P West, PhD <sup>a</sup> <sup>c</sup>, Prof Allan W Cripps, PhD <sup>a</sup>
            <sup>c</sup></div>
        <div id="author_info_ctrl"><a id="image_div_link" href="#"><span id="plusminus">+</span>
            Author Affiliations &amp; Information
        </a></div>
        <div id="author_info" class="author_info">
            <div id="author-affiliation-div">
                <div class="aff" id="aff1"><sup>a</sup> Molecular Basis of Disease, Griffith
                    University, Southport, Brisbane, QLD, Australia
                </div>
                <div class="aff" id="aff2"><sup>b</sup> Heart Foundation Research Centre, Griffith
                    University, Southport, Brisbane, QLD, Australia
                </div>
                <div class="aff" id="aff3"><sup>c</sup> Griffith Health Institute, and School of
                    Medical Science, Griffith University, Southport, Brisbane, QLD, Australia
                </div>
            </div>
            <div id="author-correspondence-div"><p class="aff" id="cor1"><sup>*</sup> Correspondence
                to: Dr Amanda J Cox, Griffith Health Institute, Griffith University, Southport, QLD
                4222, Australia <i>E-mail address:</i> <a href="mailto:a.cox@griffith.edu.au">a.cox@griffith.edu.au</a>
            </p></div>
        </div>
    </div>
    <div id="front-keywords"></div>
</div>
<div id="ja50-ce-abstract" class="ja50-ce-abstract">
    <div id="lv_0001" class="level1">
        <small>Summary</small>
    </div>
    <div class="ja50-ce-abstract-section"><p class="normal">As the prevalence of obesity and
        associated disease continues to rise and concerns for the spiralling economic and social
        costs also escalate, innovative management strategies beyond primary prevention and
        traditional lifestyle interventions are urgently needed. The biological basis of disease is
        one avenue for further exploration in this context. Several key inflammatory markers have
        been consistently associated with both obesity and risk of adverse outcomes in
        obesity-associated diseases, which suggests that a persistent, low-grade, inflammatory
        response is a potentially modifiable risk factor. In this Review, we provide evidence
        supporting perturbation of the intestinal microbiota and changes in intestinal permeability
        as potential triggers of inflammation in obesity. Further characterisation of the mechanisms
        underpinning the triggers of such inflammatory responses in overweight and obese individuals
        could offer unique opportunities for intervention strategies to help ameliorate the risk of
        obesity-associated disease.</p></div>
</div>
<hr class="hrabstract"></hr>
<div id="id-body" class="journal-body">
    <div id="lv_0002" class="level1"></div>
    <div id="cesec10"></div>
    <div id="lv_0003" class="level2">Introduction</div>
    <p class="indent">Obesity is now a global health issue, with overnutrition and excess bodyweight
        having a similar prevalence to undernutrition.<a title="References" name="back-bib1"
                                                         onmouseover="this.style.cursor='pointer'"
                                                         onfocus="this.blur();"
                                                         onclick="showPopupMulti('bib1');"><sup>1</sup></a>
        Present WHO statistics report that up to 35% of adults aged more than 20 years are currently
        considered overweight (BMI &gt;25 kg/m<sup>2</sup>), and 11% are obese (BMI &gt;30 kg/m<sup>2</sup>),
        meaning that almost 2·5 billion people are affected. Excess bodyweight has been identified
        as the fifth leading risk factor for death globally.<a title="References" name="back-bib2"
                                                               onmouseover="this.style.cursor='pointer'"
                                                               onfocus="this.blur();"
                                                               onclick="showPopupMulti('bib2');"><sup>2</sup></a>
        However, of the top four leading risk factors for death, high blood pressure, high blood
        glucose, and physical inactivity could contribute to, or result from, excess bodyweight,
        which emphasises the immense problem of obesity in relation to morbidity and mortality.</p>

    <p class="indent">The aetiology of obesity is complex and includes both biological and
        environmental factors, which contribute to consumption of a high-calorie diet and reduced
        physical activity. Indeed, in many high-income countries where sedentary lifestyles are
        becoming predominant, more than 60% of adults are regarded as overweight or obese.<a
                title="ref4" name="back-bib3" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();"
                onclick="showPopupMulti('bib3');"><sup>3</sup></a><sup>, </sup><a title="ref4"
                                                                                  name="back-bib4"
                                                                                  onmouseover="this.style.cursor='pointer'"
                                                                                  onfocus="this.blur();"
                                                                                  onclick="showPopupMulti('bib4');"><sup>4</sup></a><sup>, </sup><a
                title="ref4" name="back-bib5" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib5');"><sup>5</sup></a> The
        increasing prevalence of obesity-associated diseases, including metabolic syndrome
        (encompassing hypertension, dyslipidaemia, and insulin resistance), type 2 diabetes,
        cardiovascular disease, end-stage renal disease, and non-alcoholic fatty liver disease, is
        therefore not surprising.</p>

    <p class="indent">The social and economic implications of this global obesity epidemic are
        extensive. At an individual level, health-care expenditure for obese individuals is 1·5—1·8
        times greater than that for non-obese individuals.<a title="References" name="back-bib6"
                                                             onmouseover="this.style.cursor='pointer'"
                                                             onfocus="this.blur();"
                                                             onclick="showPopupMulti('bib6');"><sup>6</sup></a>
        In addition to direct economic costs, indirect costs related to absenteeism, lost
        productivity, and premature mortality further reinforce the potentially catastrophic
        economic consequences of the burgeoning obesity issue.</p>

    <div id="cesec20"></div>
    <div id="lv_0004" class="level2">Inflammation as a key component of obesity-associated disease
    </div>
    <p class="indent">Inflammation has been implicated in efforts to better understand the
        biological underpinnings of risk of obesity and associated disease. Indeed, many key
        inflammatory markers have been consistently associated with both obesity and risk of adverse
        outcomes in obesity-associated disease. A meta-analysis of 51 independent cross-sectional
        studies provides evidence supporting a positive association between body composition and
        C-reactive protein—a marker of systemic inflammation.<a title="References" name="back-bib7"
                                                                onmouseover="this.style.cursor='pointer'"
                                                                onfocus="this.blur();"
                                                                onclick="showPopupMulti('bib7');"><sup>7</sup></a>
        Similar associations have also been reported for erythrocyte sedimentation rate,<a
                title="References" name="back-bib8" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib8');"><sup>8</sup></a>
        plasminogen-activator inhibitor 1,<a title="References" name="back-bib9"
                                             onmouseover="this.style.cursor='pointer'"
                                             onfocus="this.blur();"
                                             onclick="showPopupMulti('bib9');"><sup>9</sup></a> and
        key inflammatory cytokines,<a title="ref4" name="back-bib10"
                                      onmouseover="this.style.cursor='pointer'"
                                      onfocus="this.blur();"
                                      onclick="showPopupMulti('bib10');"><sup>10</sup></a><sup>, </sup><a
                title="ref4" name="back-bib11" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib11');"><sup>11</sup></a> which
        further support the likely interplay between obesity and inflammation. Increases in a range
        of inflammatory markers have also been reproducibly associated with an increased risk of a
        range of obesity-associated diseases including cardiovascular disease<a title="ref4"
                                                                                name="back-bib12"
                                                                                onmouseover="this.style.cursor='pointer'"
                                                                                onfocus="this.blur();"
                                                                                onclick="showPopupMulti('bib12');"><sup>12</sup></a><sup>, </sup><a
                title="ref4" name="back-bib13" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib13');"><sup>13</sup></a> and type
        2 diabetes.<a title="ref4" name="back-bib14" onmouseover="this.style.cursor='pointer'"
                      onfocus="this.blur();"
                      onclick="showPopupMulti('bib14');"><sup>14</sup></a><sup>, </sup><a
                title="ref4" name="back-bib15" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib15');"><sup>15</sup></a></p>

    <p class="indent">Despite these associations, the causal pathways underpinning the relations
        between obesity, inflammation, and risk of disease have not yet been fully identified.
        Further characterisation of the triggers of a persistent, low-grade, inflammatory response
        in overweight and obese individuals might offer unique opportunities for novel intervention
        strategies to help to ameliorate the risk of obesity-associated disease. In this Review we
        consider the interaction between the intestinal microbiota, mucosa, and associated lymphoid
        tissue as a biological network of interest in the context of obesity-associated disease.</p>

    <div id="cesec30"></div>
    <div id="lv_0005" class="level2">Obesity and the intestinal microbiota</div>
    <p class="indent">The term intestinal microbiota describes the various commensal microbial
        species (thought to be &gt;500) in the gastrointestinal tract.<a title="References"
                                                                         name="back-bib16"
                                                                         onmouseover="this.style.cursor='pointer'"
                                                                         onfocus="this.blur();"
                                                                         onclick="showPopupMulti('bib16');"><sup>16</sup></a>
        The dominant bacterial phyla in the human intestine are Bacteriodetes (eg,
        <i>Bacteriodes</i> spp), Firmicutes (eg, <i>Clostridium</i> and <i>Bacillus</i> spp), and
        Actinobacteria (eg, <i>Bifidobacterium</i> spp),<a title="References" name="back-bib17"
                                                           onmouseover="this.style.cursor='pointer'"
                                                           onfocus="this.blur();"
                                                           onclick="showPopupMulti('bib17');"><sup>17</sup></a>
        and the total number of microbes in the intestinal mucosa is estimated to exceed 100
        trillion and thought to outnumber human cells by a factor of 10.<a title="References"
                                                                           name="back-bib16"
                                                                           onmouseover="this.style.cursor='pointer'"
                                                                           onfocus="this.blur();"
                                                                           onclick="showPopupMulti('bib16');"><sup>16</sup></a>
        The resident microbiota are increasingly recognised as having crucial roles in host
        functioning, and subsequently in health and disease. Some of the major functions of the
        commensal microbiota at the intestinal mucosa include: (1) provision of resistance to
        infection by pathogenic microorganisms through direct competition for nutrients and
        attachment sites, and production of antimicrobial substances; (2) promotion of epithelial
        cell proliferation and differentiation to maintain an intact mucosal surface; (3) promotion
        of the development of the gut-associated lymphoid tissue via initiation of dendritic cell
        maturation and differentiation of B and T lymphocytes; and (4) energy harvest from
        non-digestible dietary starches.<a title="ref4" name="back-bib16"
                                           onmouseover="this.style.cursor='pointer'"
                                           onfocus="this.blur();"
                                           onclick="showPopupMulti('bib16');"><sup>16</sup></a><sup>, </sup><a
                title="ref4" name="back-bib18" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib18');"><sup>18</sup></a> The
        potential for the intestinal microbiota to contribute to energy harvest is of particular
        interest in the context of obesity.</p>

    <p class="indent">Initial evidence from animals supports the contribution of the intestinal
        microbiota to energy harvest and associations with body composition. Lower body mass and
        body fat has been reported in germ-free mice than in their wild-type counterparts,<a
                title="References" name="back-bib19" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib19');"><sup>19</sup></a> even
        after their exposure to a high-fat and sugar-rich model of a diet typically noted in
        high-income countries.<a title="References" name="back-bib20"
                                 onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                                 onclick="showPopupMulti('bib20');"><sup>20</sup></a> These results
        suggest that in the absence of a colonised gastrointestinal tract, the capability for energy
        harvest is diminished. Transplantation of wild-type microbiota to germ-free mice normalises
        bodyweight between the groups of animals.<a title="References" name="back-bib19"
                                                    onmouseover="this.style.cursor='pointer'"
                                                    onfocus="this.blur();"
                                                    onclick="showPopupMulti('bib19');"><sup>19</sup></a>
        Conversely, transplantation of microbiota from obese mice results in increased fat mass in
        germ-free animals,<a title="References" name="back-bib21"
                             onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                             onclick="showPopupMulti('bib21');"><sup>21</sup></a> which suggests a
        unique microbial composition in obese animals that favours accumulation of excess
        bodyweight. Changes in the abundance of different microbial phyla have been reported in
        mouse models in response to the introduction of high-fat diets,<a title="ref4"
                                                                          name="back-bib22"
                                                                          onmouseover="this.style.cursor='pointer'"
                                                                          onfocus="this.blur();"
                                                                          onclick="showPopupMulti('bib22');"><sup>22</sup></a><sup>, </sup><a
                title="ref4" name="back-bib23" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib23');"><sup>23</sup></a>
        suggesting that not only does the intestinal microbiota have the potential to affect body
        composition, but that dietary patterns can also change the microbial composition, further
        augmenting a propensity towards excess bodyweight.</p>

    <p class="indent">Subsequent human studies have directly compared the composition of the
        intestinal microbiota between obese and lean individuals. Ley and colleagues<a
                title="References" name="back-bib24" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib24');"><sup>24</sup></a> compared
        the composition of the faecal microbiota between 12 obese and two lean individuals and
        reported a significantly lower relative abundance of Bacteriodetes, but a higher relative
        abundance of Firmicutes in the obese individuals. Investigators of a subsequent study of 54
        adult female monozygotic and dizygotic twin pairs concordant for body composition also
        reported significantly reduced intestinal bacterial diversity, a lower relative abundance of
        Bacteriodetes, and higher relative abundance of Actinobacteria in obese compared with lean
        individuals, but no significant difference in Firmicutes.<a title="References"
                                                                    name="back-bib25"
                                                                    onmouseover="this.style.cursor='pointer'"
                                                                    onfocus="this.blur();"
                                                                    onclick="showPopupMulti('bib25');"><sup>25</sup></a>
        Other studies have produced conflicting results for intestinal microbiota, including a
        higher relative abundance of Bacteriodetes in a cohort of 68 overweight individuals compared
        with 30 lean controls;<a title="References" name="back-bib26"
                                 onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                                 onclick="showPopupMulti('bib26');"><sup>26</sup></a> no significant
        difference in the three dominant phyla between nine obese and 12 lean individuals;<a
                title="References" name="back-bib27" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib27');"><sup>27</sup></a> and no
        difference in the relative abundance of Bacteriodetes between 29 obese and 14 lean
        participants.<a title="References" name="back-bib28"
                        onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                        onclick="showPopupMulti('bib28');"><sup>28</sup></a> The small sample sizes
        and inconsistent findings between these studies suggest a need for further evidence of the
        association between the intestinal microbiota and body composition through additional
        clinical studies.</p>

    <p class="indent">Despite the logistical challenges, both dietary intervention and
        transplantation studies have also been undertaken in human beings. Increased caloric content
        (2400 kcal per day <i>vs</i> 3400 kcal per day with similar macronutrient profiles: 24%
        protein, 16% fat, and 60% carbohydrates) for only 3 days resulted in an increased abundance
        of Firmicutes and reduced abundance of Bacteriodetes with the higher calorie diet,<a
                title="References" name="back-bib27" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib27');"><sup>27</sup></a> which
        supports the theory that diet shapes the composition of the intestinal microbiota. An
        additional feeding study involving ten healthy individuals suggests that changes in the
        composition of the intestinal microbiota could occur within 24 h of initiation of a high-fat
        diet.<a title="References" name="back-bib29" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib29');"><sup>29</sup></a></p>

    <p class="indent">Changes in the intestinal microbiota in response to weight-reducing diets have
        also been documented.<a title="ref4" name="back-bib28"
                                onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                                onclick="showPopupMulti('bib28');"><sup>28</sup></a><sup>, </sup><a
                title="ref4" name="back-bib30" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();"
                onclick="showPopupMulti('bib30');"><sup>30</sup></a><sup>, </sup><a title="ref4"
                                                                                    name="back-bib31"
                                                                                    onmouseover="this.style.cursor='pointer'"
                                                                                    onfocus="this.blur();"
                                                                                    onclick="showPopupMulti('bib31');"><sup>31</sup></a>
        No changes were noted in the abundance of Bacteriodetes, but some specific Firmicutes
        species were reduced after a 4 week, low-carbohydrate, weight-reducing diet in 18 obese men.<a
                title="References" name="back-bib28" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib28');"><sup>28</sup></a> In
        another study, the relative abundance of Bacteriodetes was decreased in 17 obese men after a
        4 week, high-protein, low-carbohydrate, diet.<a title="References" name="back-bib30"
                                                        onmouseover="this.style.cursor='pointer'"
                                                        onfocus="this.blur();"
                                                        onclick="showPopupMulti('bib30');"><sup>30</sup></a>
        Lastly, the effect of food on the composition of the microbiota has been shown in a
        crossover study of 11 individuals consuming either a plant-based or animal-based diet for 5
        days, after which the composition of their gut microbiome substantially changed to reflect
        either carbohydrate or protein.<a title="References" name="back-bib31"
                                          onmouseover="this.style.cursor='pointer'"
                                          onfocus="this.blur();" onclick="showPopupMulti('bib31');"><sup>31</sup></a>
        Whether the variation in these findings can be accounted for by the different dietary
        compositions alone is unclear, and whether alterations in the intestinal microbiota that
        promote energy harvest are a cause or result of diets typical of high-income countries and
        associated increases in body mass is yet to be established. However, in view of the
        functions of the intestinal microbiota beyond energy harvest, additional mechanisms
        involving the microbiota including promotion of mucus and antimicrobial peptide secretion,<a
                title="References" name="back-bib32" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib32');"><sup>32</sup></a> and
        signalling by metabolic byproducts<a title="ref4" name="back-bib31"
                                             onmouseover="this.style.cursor='pointer'"
                                             onfocus="this.blur();"
                                             onclick="showPopupMulti('bib31');"><sup>31</sup></a><sup>, </sup><a
                title="ref4" name="back-bib33" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib33');"><sup>33</sup></a> could
        also contribute to risk of obesity and associated disease.</p>

    <div id="cesec40"></div>
    <div id="lv_0006" class="level2">Intestinal permeability</div>
    <p class="indent">The permeability of the intestinal mucosa should be finely regulated to
        facilitate any necessary absorptive functions without compromising barrier exclusion. The
        interaction between various integral membrane proteins and cytoskeletal components provides
        the structural framework to maintain integrity of the intestinal mucosa via intercellular
        tight junctions—an essential regulator of intestinal permeability. Additional factors,
        including mucus secretions from goblet cells, release of antimicrobial peptides from Paneth
        cells, and immunoglobulin secretions from resident immune cells, also contribute to
        effective barrier exclusion<a title="References" name="back-bib34"
                                      onmouseover="this.style.cursor='pointer'"
                                      onfocus="this.blur();"
                                      onclick="showPopupMulti('bib34');"><sup>34</sup></a> (<a
                title="" href="image/gr1.jpg" name="back-fig1" class="ja50-ce-cross-ref">figure
            1</a>). However, the potential for the intestinal microbiota to contribute to the
        continued remodelling of the mucosal surface<a title="References" name="back-bib16"
                                                       onmouseover="this.style.cursor='pointer'"
                                                       onfocus="this.blur();"
                                                       onclick="showPopupMulti('bib16');"><sup>16</sup></a>
        raises questions regarding how changes in the intestinal microbiota might also contribute to
        regulation of intestinal permeability. This possibility is of particular interest in view of
        the reported associations between intestinal permeability and BMI.<a title="References"
                                                                             name="back-bib35"
                                                                             onmouseover="this.style.cursor='pointer'"
                                                                             onfocus="this.blur();"
                                                                             onclick="showPopupMulti('bib35');"><sup>35</sup></a>
    </p>

    <div class="imgbor"><a href="image/gr1.jpg"><p class="img"><img src="image/gr1.jpg" alt="image"
                                                                    id="fig1"></img></p></a>

        <p class="caption"><b>Figure 1</b> <span class="caption">Key components of the intestinal barrier<br/></span><span
                class="caption">Tight-junction proteins, anti-microbial peptide secreting Paneth cells, mucin secreting goblet cells, and secretory immunoglobulin A (sIgA) contribute to effective barrier exclusion.<br/></span>
        </p></div>
    <p class="indent">Animal and in-vitro models have again been useful in gaining preliminary
        insight into the associations between the intestinal microbiota and intestinal permeability.
        In-vitro experiments have shown that exposure of cultured intestinal epithelial cells to
        both commensal and probiotic microbial species results in up-regulation and increased
        phosphorylation of key tight-junction proteins.<a title="ref4" name="back-bib36"
                                                          onmouseover="this.style.cursor='pointer'"
                                                          onfocus="this.blur();"
                                                          onclick="showPopupMulti('bib36');"><sup>36</sup></a><sup>, </sup><a
                title="ref4" name="back-bib37" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib37');"><sup>37</sup></a> In
        animal models, exposure to probiotic microbial species results in better preservation of
        tight-junction structures (viewed histologically) in response to acute infection.<a
                title="References" name="back-bib38" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib38');"><sup>38</sup></a>
        Similarly, colonisation experiments in both germ-free mice and animal models of disease
        result in up-regulation of key tight-junction proteins<a title="References"
                                                                 name="back-bib39"
                                                                 onmouseover="this.style.cursor='pointer'"
                                                                 onfocus="this.blur();"
                                                                 onclick="showPopupMulti('bib39');"><sup>39</sup></a>
        and normalisation of intestinal-barrier function.<a title="ref4" name="back-bib36"
                                                            onmouseover="this.style.cursor='pointer'"
                                                            onfocus="this.blur();"
                                                            onclick="showPopupMulti('bib36');"><sup>36</sup></a><sup>, </sup><a
                title="ref4" name="back-bib39" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib39');"><sup>39</sup></a>
        Collectively, this evidence supports the likely contribution of the intestinal microbiota to
        the regulation of intestinal permeability.</p>

    <p class="indent">So far, few human studies have directly investigated the associations between
        the intestinal microbiota and regulation of intestinal permeability. The effects of
        manipulation of the intestinal microbiota, predominately with probiotic supplements, in both
        general-population cohorts and in the context of specific disease states, have been the
        subject of many reviews.<a title="ref4" name="back-bib40"
                                   onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                                   onclick="showPopupMulti('bib40');"><sup>40</sup></a><sup>, </sup><a
                title="ref4" name="back-bib41" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();"
                onclick="showPopupMulti('bib41');"><sup>41</sup></a><sup>, </sup><a title="ref4"
                                                                                    name="back-bib42"
                                                                                    onmouseover="this.style.cursor='pointer'"
                                                                                    onfocus="this.blur();"
                                                                                    onclick="showPopupMulti('bib42');"><sup>42</sup></a>
        However, outcome measures are frequently symptom-based and objective assessment of
        intestinal permeability is often overlooked. A placebo-controlled crossover trial with seven
        healthy individuals showed increased expression of tight-junction proteins in collected
        duodenal biopsy samples after 6 h of nasogastric administration of a probiotic-containing
        solution.<a title="References" name="back-bib43" onmouseover="this.style.cursor='pointer'"
                    onfocus="this.blur();" onclick="showPopupMulti('bib43');"><sup>43</sup></a> Our
        own investigation<a title="References" name="back-bib44"
                            onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                            onclick="showPopupMulti('bib44');"><sup>44</sup></a> in 22 healthy
        active adults consuming a symbiotic supplement consisting of a four-strain probiotic, a
        prebiotic and bovine whey-derived lactoferrin, and immunoglobulins for 21 days showed no
        change in intestinal permeability assessed with a dual sugar-absorption test. By contrast, a
        much longer 14 week, double-blind, placebo-controlled study with 23 endurance-trained men
        taking a supplement consisting of six probiotic strains, showed a significant reduction in
        faecal excretion of the key tight-junction protein zonulin in response to treatment,<a
                title="References" name="back-bib45" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib45');"><sup>45</sup></a> which
        suggests preserved integrity of the intestinal mucosa. Similarly, a 9 week intervention with
        a prebiotic supplement in a Han Chinese cohort reported concomitant changes in the
        intestinal microbiota and a reduction in intestinal permeability assessed with a
        dual-sugar-absorption test.<a title="References" name="back-bib46"
                                      onmouseover="this.style.cursor='pointer'"
                                      onfocus="this.blur();"
                                      onclick="showPopupMulti('bib46');"><sup>46</sup></a> Although
        these findings broadly support the potential for targeted modulation of intestinal
        permeability, further characterisation of the relations between the composition of the
        intestinal microbiota and measures of intestinal permeability are still needed.</p>

    <div id="cesec50"></div>
    <div id="lv_0007" class="level3">Short-chain fatty acids</div>
    <p class="indent">Short-chain fatty acids have been suggested as one mediator via which
        intestinal microbiota might promote the integrity of the intestinal mucosa, although the
        mechanisms driving these effects are not yet fully identified. Short-chain fatty acids
        (mainly acetate, propionate, and butyrate) are the product of bacterial fermentation of
        non-digestible dietary starch (a recognised prebiotic), predominately in the colon.<a
                title="References" name="back-bib47" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib47');"><sup>47</sup></a> Butyrate
        particularly is recognised as the main energy source for colonic epithelial cells, and is
        thought to stimulate blood flow and the secretion of gut hormones, enhance fluid and
        electrolyte uptake, and increase mucin release,<a title="ref4" name="back-bib47"
                                                          onmouseover="this.style.cursor='pointer'"
                                                          onfocus="this.blur();"
                                                          onclick="showPopupMulti('bib47');"><sup>47</sup></a><sup>, </sup><a
                title="ref4" name="back-bib48" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib48');"><sup>48</sup></a> all of
        which contribute to a local tropic effect and maintained integrity of the intestinal mucosa.
        In vitro, short-chain fatty acid treatment of cultured, intestinal, epithelial-cell
        monolayers resulted in increased transepithelial electrical resistance.<a title="ref4"
                                                                                  name="back-bib49"
                                                                                  onmouseover="this.style.cursor='pointer'"
                                                                                  onfocus="this.blur();"
                                                                                  onclick="showPopupMulti('bib49');"><sup>49</sup></a><sup>, </sup><a
                title="ref4" name="back-bib50" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib50');"><sup>50</sup></a>
        Transepithelial electrical resistance is accepted as a surrogate indicator for permeability
        across tight junctions and, broadly speaking, increased resistance is equivalent to a
        reduction in permeability. Furthermore, in human colon-cancer cell lines butyrate has been
        shown to inhibit proliferation,<a title="References" name="back-bib51"
                                          onmouseover="this.style.cursor='pointer'"
                                          onfocus="this.blur();" onclick="showPopupMulti('bib51');"><sup>51</sup></a>
        and butyrate and propionate insufficiency has been linked to a reduction in apoptosis and
        tumorigenesis.<a title="References" name="back-bib52"
                         onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                         onclick="showPopupMulti('bib52');"><sup>52</sup></a> Collectively, this
        evidence suggests that short-chain fatty acids could contribute to regulation of cell
        cycles. The regulation of cell proliferation and apoptosis by short-chain fatty acids has
        implications for growth and shedding of intestinal epithelial cells, because the intestinal
        epithelium undergoes continuous self-renewal—a crucial process for the regulation of
        intestinal permeability.</p>

    <p class="indent">Early insights into the effects of short-chain fatty acids on intestinal
        permeability have been gained from animals. In a rodent model, perfusion of a closed segment
        of the caecum with short-chain fatty acids reduced the appearance of a radiolabelled marker
        in the mesenteric circulation by more than 50%, suggesting a reduction in the permeability
        of the intestinal mucosa in response to short-chain fatty acids exposure.<a
                title="References" name="back-bib53" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib53');"><sup>53</sup></a> In a
        mouse model, deficiency in colonic butyrate has been associated with decreased local
        metabolism and increased autophagy.<a title="References" name="back-bib54"
                                              onmouseover="this.style.cursor='pointer'"
                                              onfocus="this.blur();"
                                              onclick="showPopupMulti('bib54');"><sup>54</sup></a>
        Furthermore, a porcine-feeding study reporting a doubling of butyrate concentration in the
        proximal colon in response to raw potato starch also showed reduced cell proliferation and
        apoptosis, and increased mucin sulfuration,<a title="References" name="back-bib55"
                                                      onmouseover="this.style.cursor='pointer'"
                                                      onfocus="this.blur();"
                                                      onclick="showPopupMulti('bib55');"><sup>55</sup></a>
        which lends support to short-chain fatty acid involvement in the maintenance of both the
        structure and function of the intestinal mucosa.</p>

    <p class="indent">Translation to human clinical studies has been limited by various ethical and
        logistical challenges, and results are difficult to replicate; differences in disease
        duration and severity, existing treatment regimens, and the composition of the short-chain
        fatty acid mixtures are all potential confounding factors. However, in ulcerative colitis, a
        disease characterised by altered intestinal permeability, decreased symptom scores and
        improved histological assessment of the intestinal mucosa have been reported after
        short-chain fatty acid administration to the colorectal tissues via enema or colonic
        irrigation.<a title="References" name="back-bib56" onmouseover="this.style.cursor='pointer'"
                      onfocus="this.blur();" onclick="showPopupMulti('bib56');"><sup>56</sup></a>
        Increased concentrations of faecal short-chain fatty acids have also been reported after
        prebiotic supplementation in healthy adults<a title="References" name="back-bib57"
                                                      onmouseover="this.style.cursor='pointer'"
                                                      onfocus="this.blur();"
                                                      onclick="showPopupMulti('bib57');"><sup>57</sup></a>
        and our own study<a title="References" name="back-bib58"
                            onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                            onclick="showPopupMulti('bib58');"><sup>58</sup></a> of healthy active
        adults (<a title="" href="image/gr2.jpg" name="back-fig2" class="ja50-ce-cross-ref">figure
            2</a>). However, markers of intestinal permeability were not measured concurrently,
        which prevented further analysis of the associations between short-chain fatty acids and
        intestinal permeability in otherwise healthy groups.</p>

    <div class="imgbor"><a href="image/gr2.jpg"><p class="img"><img src="image/gr2.jpg" alt="image"
                                                                    id="fig2"></img></p></a>

        <p class="caption"><b>Figure 2</b> <span class="caption">Dietary supplementation with butyrylated high-amylose versus low-amylose maize starch<br/></span><span
                class="caption">An intervention in 41 healthy, physically active adults showed a significant increase in faecal butyrate (a short-chain fatty acid) concentrations (μmol/g) after 28 days of supplementation with a butyrylated high-amylose maize starch (HAMSB), a resistant starch, compared with supplementation with a low-amylose maize starch (LAMS). Simultaneous changes in the composition of the intestinal mucosa were also noted (error bars represent SE). *p&lt;0·05. Data from West and colleagues.<a
                title="References" name="back-bib58" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();"
                onclick="showPopupMulti('bib58');"><sup>58</sup></a><br/></span></p></div>
    <p class="indent">Beyond documenting the associations between short-chain fatty acids and
        mucosal integrity, some investigations have begun to focus on the signalling pathways
        through which short-chain fatty acids might exert their positive effects. Short-chain fatty
        acids have been identified as ligands for a series of G-protein-coupled receptors (GPRs)
        expressed on the intestinal epithelium and by adipose tissue and immune cells.<a
                title="References" name="back-bib59" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib59');"><sup>59</sup></a>
        Short-chain fatty acids differentially activate various GPRs; propionate shows the highest
        affinity for GPR41 and GRP43, acetate for GPR43, and butyrate for GPR41 and GPR109A.<a
                title="References" name="back-bib60" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib60');"><sup>60</sup></a>
        Signalling pathways activated downstream include those implicated in the regulation of
        immunity and inflammation.<a title="References" name="back-bib61"
                                     onmouseover="this.style.cursor='pointer'"
                                     onfocus="this.blur();" onclick="showPopupMulti('bib61');"><sup>61</sup></a>
        For example, cultured, intestinal, epithelial cells from GRP41 and GPR43 knockout mice show
        attenuated production of inflammatory cytokine and chemokine production in response to
        acetate and propionate,<a title="References" name="back-bib62"
                                  onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                                  onclick="showPopupMulti('bib62');"><sup>62</sup></a> and GPR43
        knockout mice have reduced histological evidence of inflammation in the intestinal mucosa,
        reduced neutrophil infiltration, and attenuated symptom presentation in a model of induced
        colitis compared with wild-type animals,<a title="References" name="back-bib63"
                                                   onmouseover="this.style.cursor='pointer'"
                                                   onfocus="this.blur();"
                                                   onclick="showPopupMulti('bib63');"><sup>63</sup></a>
        suggesting that short-chain fatty acids might exert pro-inflammatory effects. By contrast,
        acetate supplementation in germ-free mice unable to produce endogenous short-chain fatty
        acids improved indices of disease and reduced concentrations of inflammatory mediators in
        induced colitis; this effect was not reported in GPR43 knockout animals,<a
                title="References" name="back-bib64" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib64');"><sup>64</sup></a>
        suggesting that short-chain fatty acids could mediate anti-inflammatory actions via GPRs.
    </p>

    <p class="indent">Despite these contradictory findings, additional evidence supports an
        anti-inflammatory role of short-chain fatty acids in the regulation of homoeostasis at the
        intestinal mucosa. Animal experiments suggest that short-chain fatty acids promote
        differentiation and expansion of the local colonic pool of Foxp3 expressing regulatory T
        cells.<a title="ref4" name="back-bib65" onmouseover="this.style.cursor='pointer'"
                 onfocus="this.blur();"
                 onclick="showPopupMulti('bib65');"><sup>65</sup></a><sup>, </sup><a title="ref4"
                                                                                     name="back-bib66"
                                                                                     onmouseover="this.style.cursor='pointer'"
                                                                                     onfocus="this.blur();"
                                                                                     onclick="showPopupMulti('bib66');"><sup>66</sup></a>
        These cells have a central role in limiting inflammation and promoting tolerance<a
                title="References" name="back-bib67" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib67');"><sup>67</sup></a> that
        might otherwise contribute to disruption of the integrity of the intestinal mucosa.
        Additionally, Konieczna and colleagues<a title="References" name="back-bib68"
                                                 onmouseover="this.style.cursor='pointer'"
                                                 onfocus="this.blur();"
                                                 onclick="showPopupMulti('bib68');"><sup>68</sup></a>
        have reported increased frequency of peripheral blood mononuclear cells with a regulatory T
        cell phenotype in response to 8 weeks of probiotic supplementation in healthy adults, which
        further implicates the intestinal microbiota as a potential regulator of immune and
        inflammatory homoeostasis beyond the gastrointestinal tract.</p>

    <div id="cesec60"></div>
    <div id="lv_0008" class="level2">Metabolic endotoxaemia</div>
    <p class="indent">Irrespective of the underlying mechanisms, changes in intestinal permeability
        have the potential to trigger metabolic endotoxaemia, which might have implications in the
        context of risk of obesity-associated disease. Metabolic endotoxaemia describes modest
        concentrations of circulating bacterial lipopolysaccharides in response to non-infectious
        stimuli.<a title="References" name="back-bib23" onmouseover="this.style.cursor='pointer'"
                   onfocus="this.blur();" onclick="showPopupMulti('bib23');"><sup>23</sup></a>
        Lipopolysaccharide is a cell-wall component of Gram-negative bacterial species and in this
        way the intestinal microbiota represents a substantial reservoir for entry into the
        circulation. The presence of lipopolysaccharide in the circulation has been proposed to
        result from its passive diffusion across an intestinal mucosa where tight junction integrity
        has been compromised and intestinal permeability increased.<a title="References"
                                                                      name="back-bib69"
                                                                      onmouseover="this.style.cursor='pointer'"
                                                                      onfocus="this.blur();"
                                                                      onclick="showPopupMulti('bib69');"><sup>69</sup></a>
        Active transport pathways have also been implicated in metabolic endotoxaemia.
        Lipopolysaccharides are incorporated in chylomicron fractions,<a title="ref4"
                                                                         name="back-bib70"
                                                                         onmouseover="this.style.cursor='pointer'"
                                                                         onfocus="this.blur();"
                                                                         onclick="showPopupMulti('bib70');"><sup>70</sup></a><sup>, </sup><a
                title="ref4" name="back-bib71" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib71');"><sup>71</sup></a>
        suggesting that active absorption across the intestinal mucosa as part of normal digestion
        and absorption could also account for the presence of lipopolysaccharide in the circulation.
        Despite the associations between obesity and metabolic endotoxaemia, the direction of
        causality has yet to be established.</p>

    <p class="indent">In view of the potential for active transport of lipopolysaccharide into the
        circulation it should not be surprising that diet might be one factor affecting its
        translocation across the intestinal mucosa. Consistent with several studies of dietary
        manipulation in animal models,<a title="ref4" name="back-bib22"
                                         onmouseover="this.style.cursor='pointer'"
                                         onfocus="this.blur();"
                                         onclick="showPopupMulti('bib22');"><sup>22</sup></a><sup>, </sup><a
                title="ref4" name="back-bib23" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();"
                onclick="showPopupMulti('bib23');"><sup>23</sup></a><sup>, </sup><a title="ref4"
                                                                                    name="back-bib72"
                                                                                    onmouseover="this.style.cursor='pointer'"
                                                                                    onfocus="this.blur();"
                                                                                    onclick="showPopupMulti('bib72');"><sup>72</sup></a><sup>, </sup><a
                title="ref4" name="back-bib73" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib73');"><sup>73</sup></a> the
        association between dietary composition and metabolic endotoxaemia is also evident in human
        studies. A significant positive correlation has been reported between dietary fat content
        and plasma concentrations of lipopolysaccharide in a study of 201 healthy, middle-aged men
        aged 45—64 years<a title="References" name="back-bib72"
                           onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                           onclick="showPopupMulti('bib72');"><sup>72</sup></a> and a small feeding
        study (n=8) showed increased plasma lipopolysaccharide (about 70%) after a month-long diet
        typical of high-income countries (40% fat).<a title="References" name="back-bib74"
                                                      onmouseover="this.style.cursor='pointer'"
                                                      onfocus="this.blur();"
                                                      onclick="showPopupMulti('bib74');"><sup>74</sup></a>
        Data also suggest that metabolic endotoxaemia could be both an acute and a chronic
        occurrence. Comparison of two groups of ten healthy, lean, individuals consuming a high-fat
        (about 42% fat) or an isocaloric, low-fat, high-fibre meal (about 27% fat) showed a
        significant increase in plasma lipopolysaccharide (about 50%) 3 h after the high-fat meal
        only,<a title="References" name="back-bib75" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib75');"><sup>75</sup></a> and, in
        a follow-up study, increased circulating lipopolysaccharide concentrations persisted up to 5
        hours postprandially.<a title="References" name="back-bib76"
                                onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                                onclick="showPopupMulti('bib76');"><sup>76</sup></a> Additional
        studies including a randomised crossover trial with 20 healthy men<a title="References"
                                                                             name="back-bib77"
                                                                             onmouseover="this.style.cursor='pointer'"
                                                                             onfocus="this.blur();"
                                                                             onclick="showPopupMulti('bib77');"><sup>77</sup></a>
        and another study with 12 healthy men<a title="References" name="back-bib70"
                                                onmouseover="this.style.cursor='pointer'"
                                                onfocus="this.blur();"
                                                onclick="showPopupMulti('bib70');"><sup>70</sup></a>
        both reported significant increases in plasma lipopolysaccharide concentrations within 1 h
        after a high-fat meal. These data support the potential for transient fluctuations in plasma
        lipopolysaccharide in response to high-fat feeding; however, the small sample sizes and
        inconsistencies in the time-course of lipopolysaccharide kinetics suggest that further
        characterisation of these responses is still needed, especially responses to the
        macronutrient composition of a diet typically noted in high-income countries.</p>

    <div id="cesec70"></div>
    <div id="lv_0009" class="level3">Obesity-associated disease</div>
    <p class="indent">The potential implications of metabolic endotoxaemia in the context of risk of
        obesity-associated disease are implied in many review articles;<a title="ref4"
                                                                          name="back-bib69"
                                                                          onmouseover="this.style.cursor='pointer'"
                                                                          onfocus="this.blur();"
                                                                          onclick="showPopupMulti('bib69');"><sup>69</sup></a><sup>, </sup><a
                title="ref4" name="back-bib78" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();"
                onclick="showPopupMulti('bib78');"><sup>78</sup></a><sup>, </sup><a title="ref4"
                                                                                    name="back-bib79"
                                                                                    onmouseover="this.style.cursor='pointer'"
                                                                                    onfocus="this.blur();"
                                                                                    onclick="showPopupMulti('bib79');"><sup>79</sup></a>
        however, epidemiological studies with clear data supporting these associations are scarce.
        Weidermann and colleagues<a title="References" name="back-bib80"
                                    onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                                    onclick="showPopupMulti('bib80');"><sup>80</sup></a> first
        suggested that circulating lipopolysaccharide was a risk factor for cardiovascular disease
        on the basis of an analysis of chronic infection rates in the Bruneck Study cohort of
        middle-aged older adults (approximately 450 participants aged 50—79 years) over the 5 years
        of follow-up; lipopolysaccharide concentrations were significantly higher in individuals who
        developed carotid atherosclerosis than in those who did not. A subsequent analysis in the
        FINRISK study<a title="References" name="back-bib81"
                        onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                        onclick="showPopupMulti('bib81');"><sup>81</sup></a> examining risk factors
        of chronic diseases extended these findings; in a subset of approximately 480 adults from
        the FINRISK92 cohort followed up over a 10-year period, there was a 1·8 times increased risk
        of cardiovascular disease events (fatal and non-fatal) for individuals with endotoxin
        concentrations in the upper quartile. Collectively, these data support an association
        between circulating endotoxin and risk of cardiovascular disease, but do not provide
        evidence for a causal association or insights into a possible underlying mechanism.</p>

    <p class="indent">Data also implicate circulating endotoxin in the risk of type 2 diabetes.
        Higher plasma endotoxin concentrations have been reported in a sample of 25 middle-aged
        individuals with type 2 diabetes, compared with a matched-control group.<a
                title="References" name="back-bib82" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib82');"><sup>82</sup></a> Higher
        circulating endotoxin concentrations have also been reported in a cohort of 346 individuals
        with type 2 diabetes receiving treatment across several modalities, which suggests that
        glycaemic control itself is not associated with the regulation of metabolic endotoxaemia.<a
                title="References" name="back-bib83" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib83');"><sup>83</sup></a> A larger
        analysis of the FINRISK97 cohort<a title="References" name="back-bib84"
                                           onmouseover="this.style.cursor='pointer'"
                                           onfocus="this.blur();"
                                           onclick="showPopupMulti('bib84');"><sup>84</sup></a>
        (approximately 6600 participants) showed that circulating endotoxin concentrations at
        baseline were substantially higher in the participants with type 2 diabetes than in healthy
        individuals, and predicted development of type 2 diabetes during the 10-year follow-up; for
        individuals with endotoxin concentrations in the upper quartile, the risk of type 2 diabetes
        during follow-up increased by 1·5 times. In view of these associations, understanding the
        physiological responses to circulating endotoxin could provide further insight into the
        pathogenesis of obesity-associated disease.</p>

    <div id="cesec80"></div>
    <div id="lv_0010" class="level3">Inflammation</div>
    <p class="indent">In addition to originating from the commensal intestinal microbiota,
        lipopolysaccharides represent key components of Gram-negative pathogenic strains and are
        recognised by pattern-recognition receptors that play a crucial part in the activation of
        immune and inflammatory pathways. Responses to circulating lipopolysaccharides are well
        characterised in models of infection and sepsis, but activation of similar signalling
        pathways would also be expected in metabolic endotoxaemia and could provide insight into how
        the interplay between the commensal microbiota and the immune system might contribute to
        risk of obesity-related disease.</p>

    <p class="indent">Briefly, once in the circulation lipopolysaccharides bind to
        lipopolysaccharide-binding protein (LBP), a constitutively expressed plasma protein that
        facilitates the interaction between lipopolysaccharides and various receptors and binding
        sites.<a title="References" name="back-bib85" onmouseover="this.style.cursor='pointer'"
                 onfocus="this.blur();" onclick="showPopupMulti('bib85');"><sup>85</sup></a> LBP can
        also facilitate the transfer of lipopolysaccharide to lipoproteins—HDL has the greatest
        capacity for binding lipopolysaccharide.<a title="References" name="back-bib86"
                                                   onmouseover="this.style.cursor='pointer'"
                                                   onfocus="this.blur();"
                                                   onclick="showPopupMulti('bib86');"><sup>86</sup></a>
        Tethering of lipopolysaccharide to lipoproteins can reduce the biological activity of
        lipopolysaccharide and allows for hepatic clearance.<a title="References" name="back-bib85"
                                                               onmouseover="this.style.cursor='pointer'"
                                                               onfocus="this.blur();"
                                                               onclick="showPopupMulti('bib85');"><sup>85</sup></a>
        In fact, increased circulating concentrations of LBP have been reported to parallel
        increases in lipopolysaccharide in acute infection or sepsis,<a title="ref4"
                                                                        name="back-bib87"
                                                                        onmouseover="this.style.cursor='pointer'"
                                                                        onfocus="this.blur();"
                                                                        onclick="showPopupMulti('bib87');"><sup>87</sup></a><sup>, </sup><a
                title="ref4" name="back-bib88" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib88');"><sup>88</sup></a>
        providing a mechanism for lipopolysaccharide clearance. Increased circulating LBP
        concentrations have been reported in obese individuals<a title="ref4" name="back-bib89"
                                                                 onmouseover="this.style.cursor='pointer'"
                                                                 onfocus="this.blur();"
                                                                 onclick="showPopupMulti('bib89');"><sup>89</sup></a><sup>, </sup><a
                title="ref4" name="back-bib90" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib90');"><sup>90</sup></a> and are
        probable triggers for further downstream signalling from lipopolysacharide, contributing to
        a persistent low-grade inflammatory response.</p>

    <p class="indent">Lipopolysaccharide—LBP binding allows for activation of several classic immune
        pathways, including nuclear factor-κB (NF-κB) activation and subsequent inflammatory
        responses. The associated widespread signalling networks clearly implicate cluster of
        differentiation 14 (CD14) and toll-like receptor 4 (TLR4) cell-surface molecules.<a
                title="ref4" name="back-bib79" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();"
                onclick="showPopupMulti('bib79');"><sup>79</sup></a><sup>, </sup><a title="ref4"
                                                                                    name="back-bib91"
                                                                                    onmouseover="this.style.cursor='pointer'"
                                                                                    onfocus="this.blur();"
                                                                                    onclick="showPopupMulti('bib91');"><sup>91</sup></a><sup>, </sup><a
                title="ref4" name="back-bib92" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib92');"><sup>92</sup></a> Animal
        models of TLR4 mutants or knock-outs,<a title="ref4" name="back-bib93"
                                                onmouseover="this.style.cursor='pointer'"
                                                onfocus="this.blur();"
                                                onclick="showPopupMulti('bib93');"><sup>93</sup></a><sup>, </sup><a
                title="ref4" name="back-bib94" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib94');"><sup>94</sup></a> and a
        clinical trial involving infusion of an anti-CD14 antibody,<a title="ref4" name="back-bib95"
                                                                      onmouseover="this.style.cursor='pointer'"
                                                                      onfocus="this.blur();"
                                                                      onclick="showPopupMulti('bib95');"><sup>95</sup></a><sup>, </sup><a
                title="ref4" name="back-bib96" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib96');"><sup>96</sup></a> all
        showed attenuated inflammatory responses to lipopolysaccharide exposure and contribute to
        the body of evidence supporting the role of CD14 and TLR4 signalling in mediating the
        inflammatory response to lipopolysaccharide exposure.</p>

    <p class="indent">TLR4 expression on immune cells, including monocytes, macrophages, and
        neutrophils, and non-immune cells, including adipocytes and endothelial cells,<a
                title="ref4" name="back-bib78" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();"
                onclick="showPopupMulti('bib78');"><sup>78</sup></a><sup>, </sup><a title="ref4"
                                                                                    name="back-bib92"
                                                                                    onmouseover="this.style.cursor='pointer'"
                                                                                    onfocus="this.blur();"
                                                                                    onclick="showPopupMulti('bib92');"><sup>92</sup></a>
        allows for both systemic and local inflammatory responses to lipopolysaccharides, which
        might be particularly relevant in the context of obesity-associated disease. Indeed,
        lipopolysaccharide-signalling pathways have been investigated as risk factors for both
        insulin resistance and cardiovascular disease. Impaired insulin-stimulated glucose uptake in
        cultured adipocytes after lipopolysaccharide exposure and activation of TLR4-signalling
        pathways has been reported,<a title="References" name="back-bib97"
                                      onmouseover="this.style.cursor='pointer'"
                                      onfocus="this.blur();"
                                      onclick="showPopupMulti('bib97');"><sup>97</sup></a>
        implicating lipopolysaccharide signalling as a potential contributor to insulin resistance.
        Subsequently, Cani and colleagues<a title="References" name="back-bib23"
                                            onmouseover="this.style.cursor='pointer'"
                                            onfocus="this.blur();"
                                            onclick="showPopupMulti('bib23');"><sup>23</sup></a>
        showed that chronic experimental endotoxaemia was associated with an increase in bodyweight,
        adipocyte size, glycaemia, and insulin resistance, but that this series of responses was
        attenuated in CD14-deficient mice. These findings are consistent with those reported by
        Tsukumo and colleagues<a title="References" name="back-bib98"
                                 onmouseover="this.style.cursor='pointer'" onfocus="this.blur();"
                                 onclick="showPopupMulti('bib98');"><sup>98</sup></a> in a similar
        experiment with TLR4-deficient mice, for which it was also concluded that lipopolysaccharide
        signalling through the TLR4 or CD14 pathways contributes to risk of metabolic dysregulation.
        Lastly, a study with a TLR4-deficient, atherosclerosis-prone mouse model has reported
        reduced plaque-lipid content, reduced macrophage infiltration, and reduced total
        atherosclerotic lesion area in TLR4-deficient animals,<a title="References"
                                                                 name="back-bib99"
                                                                 onmouseover="this.style.cursor='pointer'"
                                                                 onfocus="this.blur();"
                                                                 onclick="showPopupMulti('bib99');"><sup>99</sup></a>
        implicating the TLR4-signalling pathway in contributing to atherogenesis, which is
        particularly relevant in the context of obesity-associated disease.</p>

    <p class="indent">Consideration of the various physiological responses to lipopolysaccharide
        would be incomplete without acknowledging that increased intestinal permeability has been
        described in sepsis. Results from animals suggest that high plasma lipopolysaccharide
        concentrations could trigger further disruption of the integrity of the intestinal mucosa,<a
                title="ref4" name="back-bib100" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();"
                onclick="showPopupMulti('bib100');"><sup>100</sup></a><sup>, </sup><a title="ref4"
                                                                                      name="back-bib101"
                                                                                      onmouseover="this.style.cursor='pointer'"
                                                                                      onfocus="this.blur();"
                                                                                      onclick="showPopupMulti('bib101');"><sup>101</sup></a>
        and human studies support the potential for changes in intestinal permeability in response
        to lipopolysaccharide exposure. Jorgensen and colleagues<a title="References"
                                                                   name="back-bib102"
                                                                   onmouseover="this.style.cursor='pointer'"
                                                                   onfocus="this.blur();"
                                                                   onclick="showPopupMulti('bib102');"><sup>102</sup></a>
        reported increased plasma presence of a radiolabelled marker given via colonic enema to a
        group of nine patients with sepsis compared with healthy controls, suggesting an increase in
        intestinal permeability in response to lipopolysaccharide. Investigators of a subsequent
        study of ten healthy young adults reported increased intestinal permeability, assessed by
        urinary recovery of orally administered polyethylene glycols, in response to
        lipopolysaccharide infusion.<a title="References" name="back-bib103"
                                       onmouseover="this.style.cursor='pointer'"
                                       onfocus="this.blur();"
                                       onclick="showPopupMulti('bib103');"><sup>103</sup></a>
        Increased plasma concentrations of the tight-junction protein zonulin have been reported in
        a cohort of 25 patients with sepsis compared with a healthy control group, suggesting the
        potential for shedding of tight-junction proteins in sepsis, disruption of the structural
        integrity of the intestinal mucosa, and increased intestinal permeability.<a
                title="References" name="back-bib104" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib104');"><sup>104</sup></a></p>

    <p class="indent">Whether additional changes in intestinal permeability happen as a result of
        metabolic endotoxaemia is unclear. Indeed, the threshold for lipopolysaccharide to elicit
        further disruptions in intestinal permeability might vary between individuals and be
        affected by rates of lipopolysaccharide clearance, which is itself affected by the ability
        to upregulate LBP. However, if metabolic endotoxaemia itself is a sufficient trigger to
        induce further increases in intestinal permeability, increased lipopolysaccharide
        translocation across the intestinal mucosa would also be expected. This sequence of events
        could occur in a pulsatile manner—eg, in response to repeated exposure to a high-fat diet
        that is typical in obesity, and has the potential to establish a self-propagating circuit
        driving a chronic, low-grade inflammatory response (<a title="" href="image/gr3.jpg"
                                                               name="back-fig3"
                                                               class="ja50-ce-cross-ref">figure
            3</a>). Modulation of this response via manipulation of the intestinal microbiota to
        maintain intestinal permeability is an attractive possibility and worth further
        consideration, particularly because data from animal studies with both prebiotics<a
                title="References" name="back-bib105" onmouseover="this.style.cursor='pointer'"
                onfocus="this.blur();" onclick="showPopupMulti('bib105');"><sup>105</sup></a> and
        probiotics<a title="References" name="back-bib106" onmouseover="this.style.cursor='pointer'"
                     onfocus="this.blur();" onclick="showPopupMulti('bib106');"><sup>106</sup></a>
        show evidence of improved intestinal permeability, and metabolic and inflammatory status.
    </p>

    <div class="imgbor"><a href="image/gr3.jpg"><p class="img"><img src="image/gr3.jpg" alt="image"
                                                                    id="fig3"></img></p></a>

        <p class="caption"><b>Figure 3</b> <span class="caption">Proposed model of how repeated exposure to a high-fat diet could lead to a low-grade inflammatory response<br/></span><span
                class="caption">Repeated exposure to a high-fat diet that is typical in people with obesity could trigger pulsatile fluctuations in circulating LPS concentrations, repeated activation of immune signalling pathways, and a chronic low-grade inflammatory response. LPS=lipopolysaccharide.<br/></span>
        </p></div>
    <div id="cesec90"></div>
    <div id="lv_0011" class="level2">Linking intestinal microbiota with inflammation and
        obesity-associated disease
    </div>
    <p class="indent">In view of the increasing prevalence of obesity and associated disease,
        particularly in high-income nations, and the growing concerns about the economic and social
        costs of obesity, management strategies beyond primary prevention and traditional lifestyle
        interventions are increasingly warranted. This Review has focused on the intestinal mucosa
        as one component of a complex biological system for which the potential for innovative
        intervention approaches could exist.</p>

    <p class="indent">The published literature contains many review articles speculating on the
        potential associations between obesity, the gut microbiota, and disease. However, in this
        Review we recognised a notable, and frequently unacknowledged, shortcoming that several key
        assertions in this specialty are based on a limited number of often small-scale, studies.
        Furthermore, some results are conflicting and have not been replicated more widely in
        clinical studies, thereby limiting translation to clinical practice via improved risk
        prediction, or targeted treatment and management strategies. A range of ethical and
        logistical issues are associated with such studies that might have restricted progress in
        this field. However, further translational research should be promoted to substantiate
        in-vitro and animal experiments.</p>

    <p class="indent">Many reports collectively implicate the interplay between the intestinal
        microbiota, intestinal permeability, and the immune system as one mechanism linking diet,
        obesity, and associated disease. We suggest that alterations in the intestinal microbiota
        affect intestinal permeability and that the resultant activation of immune-signalling
        pathways contributes to a chronic, low-grade inflammatory response that is associated with
        an increased risk of obesity-associated disease (<a title="" href="image/gr4.jpg"
                                                            name="back-fig4"
                                                            class="ja50-ce-cross-ref">figure 4</a>).
        Modulation of intestinal permeability through interventions that modify the composition of
        the intestinal microbiota, or activation of the immune system and associated inflammatory
        responses, could be a key strategy to address obesity and obesity-related disease.</p>

    <div class="imgbor"><a href="image/gr4.jpg"><p class="img"><img src="image/gr4.jpg" alt="image"
                                                                    id="fig4"></img></p></a>

        <p class="caption"><b>Figure 4</b> <span class="caption">Potential links between diet, obesity, and obesity-associated disease<br/></span><span
                class="caption">The interplay between the intestinal microbiota, intestinal permeability, and the immune system depicted as one mechanism linking diet, obesity, and obesity-associated disease. TLR=toll-like receptor. SCFA=short-chain fatty acid. LPS=lipopolysaccharide.<br/></span>
        </p></div>
    <div id="cesec100"></div>
    <div id="lv_0012" class="level2">Search strategy and selection criteria</div>
    <p class="indent">

    <div class="ja50-ce-textbox" id="cetextbox10">
        <div class="ja50-ce-textbox-body1">
            <div id="lv_0013" class="level1"></div>
            <p class="indent1">We identified English-language material published from Jan 1, 1990,
                to Feb 28, 2014, through a PubMed search with combinations of the terms
                “inflammation”, “obesity”, “microbiota”, “microflora”, “intestinal”, “gut”,
                “permeability”, “metabolic endotoxaemia”, “tight junction”, “probiotic”, “short
                chain fatty acids”, and “butyrate”. We initially limited the results to relevant
                review articles and sourced original investigations from citations in these
                articles. We identified additional original investigations through further PubMed
                searches as described, but without the “review” limitations.</p></div>
    </div>
    </p><p class="indent"><strong>Contributors</strong></p>

    <p class="indent">AJC searched the published literature, assisted by NPW. Information was
        synthesised by AJC, assisted by NPW and AWC. AJC drafted the Review, and NPW and AWC revised
        and edited the manuscript.</p>

    <p class="indent"><strong>Declaration of interests</strong></p>

    <p class="indent">NPW and AWC have received industry research grants from DuPont Nutrition and
        Health (Kantvik, Finland), and Probiotec Pharma Pty Ltd (Victoria, Australia). AJC has
        received industry research grants from Probiotec Pharma Pty Ltd (Victoria, Australia).</p>
</div>
<div id="yoasNoAbstractFragment"></div>
<hr class="hrreference"></hr>
<div id="bibliography" class="bibliography">
    <div id="lv_0014" class="level2">References</div>
    <div class="refshow" id="bib1"><a class="back-bib" href="#back-bib1">1</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span
            class="ja50-sb-collaboration">World Obesity Federation</span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">About obesity</span></span></span>.
        <span class="ja50-sb-host"><a class="ja50-ce-inter-ref"
                                      href="http://www.iaso.org/resources/aboutobesity/"
                                      target="_blank">http://www.iaso.org/resources/aboutobesity/</a>. </span><span
                class="ja50-sb-comment">(accessed Jan 16, 2014). </span></div>
    <div class="refshow" id="bib2"><a class="back-bib" href="#back-bib2">2</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span
            class="ja50-sb-collaboration">WHO</span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Global Health Risks—mortality and burden of disease attributable to selected major risks</span></span></span>.
        <span class="ja50-sb-host"><a class="ja50-ce-inter-ref"
                                      href="http://www.who.int.healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf"
                                      target="_blank">http://www.who.int.healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf</a>. </span><span
                class="ja50-sb-comment">(accessed Jan 16, 2014). </span></div>
    <div class="refshow" id="bib3"><a class="back-bib" href="#back-bib3">3</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span
            class="ja50-sb-collaboration">Centers for Disease Control and Prevention</span></span>. <span
            class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Health. United States</span></span></span>. <span
            class="ja50-sb-host"><a class="ja50-ce-inter-ref"
                                    href="http://www.cdc.gov/nchs/data/hus/hus12.pdf"
                                    target="_blank">http://www.cdc.gov/nchs/data/hus/hus12.pdf</a>. </span><span
            class="ja50-sb-comment">(accessed Jan 16, 2014). </span></div>
    <div class="refshow" id="bib4"><a class="back-bib" href="#back-bib4">4</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span
            class="ja50-sb-collaboration">Health and Social Care Information Centre</span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Statistics on obesity, physical activity and diet: England</span></span></span>.
        <span class="ja50-sb-host"><a class="ja50-ce-inter-ref"
                                      href="http://www.hscic.gov.uk/catalogue/PUB10364/obes-phys-acti-diet-eng-2013-rep.pdf"
                                      target="_blank">http://www.hscic.gov.uk/catalogue/PUB10364/obes-phys-acti-diet-eng-2013-rep.pdf</a>. </span><span
                class="ja50-sb-comment">(accessed Jan 16, 2014). </span></div>
    <div class="refshow" id="bib5"><a class="back-bib" href="#back-bib5">5</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span
            class="ja50-sb-collaboration">Australian Bureau of Statistics</span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Australian Health Survey, 2011—2012</span></span></span>.
        <span class="ja50-sb-host"><a class="ja50-ce-inter-ref"
                                      href="http://www.ausstats.abs.gov.au/Ausstats/subscriber.nsf/0/1680ECA402368CCFCA257AC90015AA4E/$File/4364.0.55.001.pdf"
                                      target="_blank">http://www.ausstats.abs.gov.au/Ausstats/subscriber.nsf/0/1680ECA402368CCFCA257AC90015AA4E/$File/4364.0.55.001.pdf</a>. </span><span
                class="ja50-sb-comment">(accessed Jan 16, 2014). </span></div>
    <div class="refshow" id="bib6"><a class="back-bib" href="#back-bib6">6</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Cawley</span> <span class="ja50-ce-given-name">J</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Meyerhoefer</span> <span
            class="ja50-ce-given-name">C</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">The medical care costs of obesity: an instrumental variables approach</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Health Econ</span></span> <span class="ja50-sb-date">2012</span>; <span
                class="ja50-sb-volume-nr">31</span>: </span><span
                class="ja50-sb-pages">219-230</span>. </span></div>
    <div class="refshow" id="bib7"><a class="back-bib" href="#back-bib7">7</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Choi</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Joseph</span> <span class="ja50-ce-given-name">L</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Pilote</span> <span
            class="ja50-ce-given-name">L</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Obesity and C-reactive protein in various populations: a systematic review and meta-analysis</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Obes Rev</span></span> <span
                class="ja50-sb-date">2013</span>; <span class="ja50-sb-volume-nr">14</span>: </span><span
                class="ja50-sb-pages">232-244</span>. </span></div>
    <div class="refshow" id="bib8"><a class="back-bib" href="#back-bib8">8</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">de Rooij</span> <span
            class="ja50-ce-given-name">SR</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Nijpels</span> <span
            class="ja50-ce-given-name">G</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Nilsson</span> <span class="ja50-ce-given-name">PM</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease (RISC) population: associations with insulin resistance and cardiometabolic risk profile</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Diabetes Care</span></span> <span class="ja50-sb-date">2009</span>; <span
                class="ja50-sb-volume-nr">32</span>: </span><span
                class="ja50-sb-pages">1295-1301</span>. </span></div>
    <div class="refshow" id="bib9"><a class="back-bib" href="#back-bib9">9</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Mavri</span> <span
            class="ja50-ce-given-name">A</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Alessi</span> <span
            class="ja50-ce-given-name">MC</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Bastelica</span> <span
            class="ja50-ce-given-name">D</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Diabetologia</span></span> <span
                class="ja50-sb-date">2001</span>; <span class="ja50-sb-volume-nr">44</span>: </span><span
                class="ja50-sb-pages">2025-2031</span>. </span></div>
    <div class="refshow" id="bib10"><a class="back-bib" href="#back-bib10">10</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Bahceci</span> <span
            class="ja50-ce-given-name">M</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Gokalp</span> <span class="ja50-ce-given-name">D</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Bahceci</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Tuzcu</span> <span
            class="ja50-ce-given-name">A</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Atmaca</span> <span class="ja50-ce-given-name">S</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Arikan</span> <span
            class="ja50-ce-given-name">S</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults?</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Endocrinol Invest</span></span> <span
                class="ja50-sb-date">2007</span>; <span class="ja50-sb-volume-nr">30</span>: </span><span
                class="ja50-sb-pages">210-214</span>. </span></div>
    <div class="refshow" id="bib11"><a class="back-bib" href="#back-bib11">11</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Marques-Vidal</span> <span class="ja50-ce-given-name">P</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Bochud</span> <span
            class="ja50-ce-given-name">M</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Bastardot</span> <span
            class="ja50-ce-given-name">F</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Association between inflammatory and obesity markers in a Swiss population-based sample (CoLaus Study)</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Obes Facts</span></span> <span
                class="ja50-sb-date">2012</span>; <span
                class="ja50-sb-volume-nr">5</span>: </span><span
                class="ja50-sb-pages">734-744</span>. </span></div>
    <div class="refshow" id="bib12"><a class="back-bib" href="#back-bib12">12</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Schnabel</span> <span
            class="ja50-ce-given-name">RB</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Yin</span> <span
            class="ja50-ce-given-name">X</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Larson</span> <span class="ja50-ce-given-name">MG</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Arterioscler Thromb Vasc Biol</span></span> <span
                class="ja50-sb-date">2013</span>; <span class="ja50-sb-volume-nr">33</span>: </span><span
                class="ja50-sb-pages">1728-1733</span>. </span></div>
    <div class="refshow" id="bib13"><a class="back-bib" href="#back-bib13">13</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span
            class="ja50-sb-collaboration">Emerging Risk Factors Collaboration</span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Kaptoge</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Di Angelantonio</span> <span class="ja50-ce-given-name">E</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">C-reactive protein, fibrinogen, and cardiovascular disease prediction</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">N Engl J Med</span></span> <span
                class="ja50-sb-date">2012</span>; <span
                class="ja50-sb-volume-nr">367</span>: </span><span
                class="ja50-sb-pages">1310-1320</span>. </span></div>
    <div class="refshow" id="bib14"><a class="back-bib" href="#back-bib14">14</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Spranger</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kroke</span> <span
            class="ja50-ce-given-name">A</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Mohlig</span> <span class="ja50-ce-given-name">M</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Diabetes</span></span> <span
                class="ja50-sb-date">2003</span>; <span class="ja50-sb-volume-nr">52</span>: </span><span
                class="ja50-sb-pages">812-817</span>. </span></div>
    <div class="refshow" id="bib15"><a class="back-bib" href="#back-bib15">15</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Bertoni</span> <span
            class="ja50-ce-given-name">AG</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Burke</span> <span class="ja50-ce-given-name">GL</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Owusu</span> <span
            class="ja50-ce-given-name">JA</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA)</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Diabetes Care</span></span> <span class="ja50-sb-date">2010</span>; <span
                class="ja50-sb-volume-nr">33</span>: </span><span
                class="ja50-sb-pages">804-810</span>. </span></div>
    <div class="refshow" id="bib16"><a class="back-bib" href="#back-bib16">16</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Guarner</span> <span
            class="ja50-ce-given-name">F</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Malagelada</span> <span
            class="ja50-ce-given-name">JR</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Gut flora in health and disease</span></span></span>. <span
            class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Lancet</span></span> <span
            class="ja50-sb-date">2003</span>; <span
            class="ja50-sb-volume-nr">361</span>: </span><span class="ja50-sb-pages">512-519</span>. </span>
    </div>
    <div class="refshow" id="bib17"><a class="back-bib" href="#back-bib17">17</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Eckburg</span> <span
            class="ja50-ce-given-name">PB</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Bik</span> <span
            class="ja50-ce-given-name">EM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Bernstein</span> <span
            class="ja50-ce-given-name">CN</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Diversity of the human intestinal microbial flora</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Science</span></span> <span
                class="ja50-sb-date">2005</span>; <span
                class="ja50-sb-volume-nr">308</span>: </span><span
                class="ja50-sb-pages">1635-1638</span>. </span></div>
    <div class="refshow" id="bib18"><a class="back-bib" href="#back-bib18">18</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Tilg</span> <span
            class="ja50-ce-given-name">H</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Moschen</span> <span
            class="ja50-ce-given-name">AR</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kaser</span> <span
            class="ja50-ce-given-name">A</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Obesity and the microbiota</span></span></span>. <span
            class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Gastroenterology</span></span> <span
            class="ja50-sb-date">2009</span>; <span
            class="ja50-sb-volume-nr">136</span>: </span><span
            class="ja50-sb-pages">1476-1483</span>. </span></div>
    <div class="refshow" id="bib19"><a class="back-bib" href="#back-bib19">19</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Backhed</span> <span
            class="ja50-ce-given-name">F</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ding</span> <span
            class="ja50-ce-given-name">H</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Wang</span> <span class="ja50-ce-given-name">T</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">The gut microbiota as an environmental factor that regulates fat storage</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Proc Natl Acad Sci USA</span></span> <span
                class="ja50-sb-date">2004</span>; <span
                class="ja50-sb-volume-nr">101</span>: </span><span
                class="ja50-sb-pages">15718-15723</span>. </span></div>
    <div class="refshow" id="bib20"><a class="back-bib" href="#back-bib20">20</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ding</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Chi</span> <span
            class="ja50-ce-given-name">MM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Scull</span> <span class="ja50-ce-given-name">BP</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">PLoS One</span></span> <span
                class="ja50-sb-date">2010</span>; <span
                class="ja50-sb-volume-nr">5</span>: </span><span class="ja50-sb-pages">e12191</span>. </span>
    </div>
    <div class="refshow" id="bib21"><a class="back-bib" href="#back-bib21">21</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Turnbaugh</span> <span
            class="ja50-ce-given-name">PJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ley</span> <span
            class="ja50-ce-given-name">RE</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Mahowald</span> <span
            class="ja50-ce-given-name">MA</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Magrini</span> <span
            class="ja50-ce-given-name">V</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Mardis</span> <span
            class="ja50-ce-given-name">ER</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Gordon</span> <span class="ja50-ce-given-name">JI</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">An obesity-associated gut microbiome with increased capacity for energy harvest</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Nature</span></span> <span
                class="ja50-sb-date">2006</span>; <span
                class="ja50-sb-volume-nr">444</span>: </span><span
                class="ja50-sb-pages">1027-1031</span>. </span></div>
    <div class="refshow" id="bib22"><a class="back-bib" href="#back-bib22">22</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Cani</span> <span
            class="ja50-ce-given-name">PD</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Neyrinck</span> <span
            class="ja50-ce-given-name">AM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Fava</span> <span class="ja50-ce-given-name">F</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Diabetologia</span></span> <span
                class="ja50-sb-date">2007</span>; <span class="ja50-sb-volume-nr">50</span>: </span><span
                class="ja50-sb-pages">2374-2383</span>. </span></div>
    <div class="refshow" id="bib23"><a class="back-bib" href="#back-bib23">23</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Cani</span> <span
            class="ja50-ce-given-name">PD</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Amar</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Iglesias</span> <span
            class="ja50-ce-given-name">MA</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Metabolic endotoxemia initiates obesity and insulin resistance</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Diabetes</span></span> <span
                class="ja50-sb-date">2007</span>; <span class="ja50-sb-volume-nr">56</span>: </span><span
                class="ja50-sb-pages">1761-1772</span>. </span></div>
    <div class="refshow" id="bib24"><a class="back-bib" href="#back-bib24">24</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ley</span> <span
            class="ja50-ce-given-name">RE</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Turnbaugh</span> <span
            class="ja50-ce-given-name">PJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Klein</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Gordon</span> <span class="ja50-ce-given-name">JI</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Microbial ecology: human gut microbes associated with obesity</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Nature</span></span> <span
                class="ja50-sb-date">2006</span>; <span
                class="ja50-sb-volume-nr">444</span>: </span><span
                class="ja50-sb-pages">1022-1023</span>. </span></div>
    <div class="refshow" id="bib25"><a class="back-bib" href="#back-bib25">25</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Turnbaugh</span> <span
            class="ja50-ce-given-name">PJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Hamady</span> <span class="ja50-ce-given-name">M</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Yatsunenko</span> <span
            class="ja50-ce-given-name">T</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">A core gut microbiome in obese and lean twins</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Nature</span></span> <span
                class="ja50-sb-date">2009</span>; <span
                class="ja50-sb-volume-nr">457</span>: </span><span
                class="ja50-sb-pages">480-484</span>. </span></div>
    <div class="refshow" id="bib26"><a class="back-bib" href="#back-bib26">26</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Schwiertz</span> <span
            class="ja50-ce-given-name">A</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Taras</span> <span
            class="ja50-ce-given-name">D</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Schafer</span> <span class="ja50-ce-given-name">K</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Microbiota and SCFA in lean and overweight healthy subjects</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Obesity (Silver Spring)</span></span> <span
                class="ja50-sb-date">2010</span>; <span class="ja50-sb-volume-nr">18</span>: </span><span
                class="ja50-sb-pages">190-195</span>. </span></div>
    <div class="refshow" id="bib27"><a class="back-bib" href="#back-bib27">27</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Jumpertz</span> <span
            class="ja50-ce-given-name">R</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Le</span> <span
            class="ja50-ce-given-name">DS</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Turnbaugh</span> <span
            class="ja50-ce-given-name">PJ</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Am J Clin Nutr</span></span> <span class="ja50-sb-date">2011</span>; <span
                class="ja50-sb-volume-nr">94</span>: </span><span class="ja50-sb-pages">58-65</span>. </span>
    </div>
    <div class="refshow" id="bib28"><a class="back-bib" href="#back-bib28">28</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Duncan</span> <span
            class="ja50-ce-given-name">SH</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Lobley</span> <span
            class="ja50-ce-given-name">GE</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Holtrop</span> <span class="ja50-ce-given-name">G</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Human colonic microbiota associated with diet, obesity and weight loss</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Int J Obes</span></span> <span
                class="ja50-sb-date">2008</span>; <span class="ja50-sb-volume-nr">32</span>: </span><span
                class="ja50-sb-pages">1720-1724</span>. </span></div>
    <div class="refshow" id="bib29"><a class="back-bib" href="#back-bib29">29</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Wu</span> <span
            class="ja50-ce-given-name">GD</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Chen</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Hoffmann</span> <span class="ja50-ce-given-name">C</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Linking long-term dietary patterns with gut microbial enterotypes</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Science</span></span> <span
                class="ja50-sb-date">2011</span>; <span
                class="ja50-sb-volume-nr">334</span>: </span><span
                class="ja50-sb-pages">105-108</span>. </span></div>
    <div class="refshow" id="bib30"><a class="back-bib" href="#back-bib30">30</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Russell</span> <span
            class="ja50-ce-given-name">WR</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Gratz</span> <span class="ja50-ce-given-name">SW</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Duncan</span> <span
            class="ja50-ce-given-name">SH</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Am J Clin Nutr</span></span> <span class="ja50-sb-date">2011</span>; <span
                class="ja50-sb-volume-nr">93</span>: </span><span
                class="ja50-sb-pages">1062-1072</span>. </span></div>
    <div class="refshow" id="bib31"><a class="back-bib" href="#back-bib31">31</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">David</span> <span class="ja50-ce-given-name">LA</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Maurice</span> <span
            class="ja50-ce-given-name">CF</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Carmody</span> <span class="ja50-ce-given-name">RN</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Diet rapidly and reproducibly alters the human gut microbiome</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Nature</span></span> <span
                class="ja50-sb-date">2014</span>; <span
                class="ja50-sb-volume-nr">505</span>: </span><span
                class="ja50-sb-pages">559-563</span>. </span></div>
    <div class="refshow" id="bib32"><a class="back-bib" href="#back-bib32">32</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Everard</span> <span
            class="ja50-ce-given-name">A</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Belzer</span> <span class="ja50-ce-given-name">C</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Geurts</span> <span
            class="ja50-ce-given-name">L</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Proc Natl Acad Sci USA</span></span> <span
                class="ja50-sb-date">2013</span>; <span
                class="ja50-sb-volume-nr">110</span>: </span><span
                class="ja50-sb-pages">9066-9071</span>. </span></div>
    <div class="refshow" id="bib33"><a class="back-bib" href="#back-bib33">33</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ursell</span> <span
            class="ja50-ce-given-name">LK</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Haiser</span> <span
            class="ja50-ce-given-name">HJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Van Treuren</span> <span
            class="ja50-ce-given-name">W</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">The intestinal metabolome: an intersection between microbiota and host</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Gastroenterology</span></span> <span class="ja50-sb-date">2014</span>; <span
                class="ja50-sb-volume-nr">146</span>: </span><span
                class="ja50-sb-pages">1470-1476</span>. </span></div>
    <div class="refshow" id="bib34"><a class="back-bib" href="#back-bib34">34</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kurashima</span> <span
            class="ja50-ce-given-name">Y</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Goto</span> <span
            class="ja50-ce-given-name">Y</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kiyono</span> <span
            class="ja50-ce-given-name">H</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Mucosal innate immune cells regulate both gut homeostasis and intestinal inflammation</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Eur J Immunol</span></span> <span class="ja50-sb-date">2013</span>; <span
                class="ja50-sb-volume-nr">43</span>: </span><span
                class="ja50-sb-pages">3108-3115</span>. </span></div>
    <div class="refshow" id="bib35"><a class="back-bib" href="#back-bib35">35</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Moreno-Navarrete</span> <span
            class="ja50-ce-given-name">JM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Sabater</span> <span
            class="ja50-ce-given-name">M</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ortega</span> <span class="ja50-ce-given-name">F</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Ricart</span> <span
            class="ja50-ce-given-name">W</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Fernandez-Real</span> <span class="ja50-ce-given-name">JM</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">PLoS One</span></span> <span
                class="ja50-sb-date">2012</span>; <span
                class="ja50-sb-volume-nr">7</span>: </span><span class="ja50-sb-pages">e37160</span>. </span>
    </div>
    <div class="refshow" id="bib36"><a class="back-bib" href="#back-bib36">36</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ewaschuk</span> <span
            class="ja50-ce-given-name">JB</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Diaz</span> <span
            class="ja50-ce-given-name">H</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Meddings</span> <span class="ja50-ce-given-name">L</span></span>, et al</span>. <span
            class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Secreted bioactive factors from <i>Bifidobacterium
        infantis</i> enhance epithelial cell barrier function</span></span></span>. <span
            class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Am J Physiol Gastrointest Liver Physiol</span></span> <span
            class="ja50-sb-date">2008</span>; <span
            class="ja50-sb-volume-nr">295</span>: </span><span
            class="ja50-sb-pages">G1025-G1034</span>. </span></div>
    <div class="refshow" id="bib37"><a class="back-bib" href="#back-bib37">37</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Anderson</span> <span
            class="ja50-ce-given-name">RC</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Cookson</span> <span
            class="ja50-ce-given-name">AL</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">McNabb</span> <span
            class="ja50-ce-given-name">WC</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kelly</span> <span class="ja50-ce-given-name">WJ</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Roy</span> <span
            class="ja50-ce-given-name">NC</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle"><i>Lactobacillus plantarum</i> DSM 2648 is a potential probiotic that enhances intestinal barrier function</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">FEMS Microbiol Lett</span></span> <span
                class="ja50-sb-date">2010</span>; <span
                class="ja50-sb-volume-nr">309</span>: </span><span
                class="ja50-sb-pages">184-192</span>. </span></div>
    <div class="refshow" id="bib38"><a class="back-bib" href="#back-bib38">38</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Shen</span> <span
            class="ja50-ce-given-name">TY</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Qin</span> <span
            class="ja50-ce-given-name">HL</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Gao</span> <span
            class="ja50-ce-given-name">ZG</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Fan</span> <span
            class="ja50-ce-given-name">XB</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Hang</span> <span
            class="ja50-ce-given-name">XM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Jiang</span> <span
            class="ja50-ce-given-name">YQ</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Influences of enteral nutrition combined with probiotics on gut microflora and barrier function of rats with abdominal infection</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">World J Gastroenterol</span></span> <span
                class="ja50-sb-date">2006</span>; <span class="ja50-sb-volume-nr">12</span>: </span><span
                class="ja50-sb-pages">4352-4358</span>. </span></div>
    <div class="refshow" id="bib39"><a class="back-bib" href="#back-bib39">39</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ukena</span> <span class="ja50-ce-given-name">SN</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Singh</span> <span
            class="ja50-ce-given-name">A</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Dringenberg</span> <span
            class="ja50-ce-given-name">U</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Probiotic <i>Escherichia coli</i> Nissle 1917 inhibits leaky gut by enhancing mucosal integrity</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">PLoS One</span></span> <span
                class="ja50-sb-date">2007</span>; <span
                class="ja50-sb-volume-nr">2</span>: </span><span class="ja50-sb-pages">e1308</span>. </span>
    </div>
    <div class="refshow" id="bib40"><a class="back-bib" href="#back-bib40">40</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Whelan</span> <span class="ja50-ce-given-name">K</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Quigley</span> <span
            class="ja50-ce-given-name">EM</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Curr Opin Gastroenterol</span></span> <span
                class="ja50-sb-date">2013</span>; <span class="ja50-sb-volume-nr">29</span>: </span><span
                class="ja50-sb-pages">184-189</span>. </span></div>
    <div class="refshow" id="bib41"><a class="back-bib" href="#back-bib41">41</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Balakrishnan</span> <span class="ja50-ce-given-name">M</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Floch</span> <span
            class="ja50-ce-given-name">MH</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Prebiotics, probiotics and digestive health</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Curr Opin Clin Nutr Metab Care</span></span> <span
                class="ja50-sb-date">2012</span>; <span class="ja50-sb-volume-nr">15</span>: </span><span
                class="ja50-sb-pages">580-585</span>. </span></div>
    <div class="refshow" id="bib42"><a class="back-bib" href="#back-bib42">42</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kotzampassi</span> <span
            class="ja50-ce-given-name">K</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Giamarellos-Bourboulis</span> <span class="ja50-ce-given-name">EJ</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Probiotics for infectious diseases: more drugs, less dietary supplementation</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Int J Antimicrob Agents</span></span> <span
                class="ja50-sb-date">2012</span>; <span class="ja50-sb-volume-nr">40</span>: </span><span
                class="ja50-sb-pages">288-296</span>. </span></div>
    <div class="refshow" id="bib43"><a class="back-bib" href="#back-bib43">43</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Karczewski</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Troost</span> <span
            class="ja50-ce-given-name">FJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Konings</span> <span class="ja50-ce-given-name">I</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Regulation of human epithelial tight junction proteins by <i>Lactobacillus
        plantarum</i> in vivo and protective effects on the epithelial barrier</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Am J Physiol Gastrointest Liver Physiol</span></span> <span
                class="ja50-sb-date">2010</span>; <span
                class="ja50-sb-volume-nr">298</span>: </span><span
                class="ja50-sb-pages">G851-G859</span>. </span></div>
    <div class="refshow" id="bib44"><a class="back-bib" href="#back-bib44">44</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">West</span> <span
            class="ja50-ce-given-name">NP</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Pyne</span> <span
            class="ja50-ce-given-name">DB</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Cripps</span> <span
            class="ja50-ce-given-name">AW</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Christophersen</span> <span class="ja50-ce-given-name">CT</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Conlon</span> <span
            class="ja50-ce-given-name">MA</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Fricker</span> <span class="ja50-ce-given-name">PA</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Gut Balance, a symbiotic supplement, increases fecal <i>Lactobacillus
        paracasei</i> but has little effect on immunity in healthy physically active individuals</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Gut Microbes</span></span> <span
                class="ja50-sb-date">2012</span>; <span
                class="ja50-sb-volume-nr">3</span>: </span><span
                class="ja50-sb-pages">221-227</span>. </span></div>
    <div class="refshow" id="bib45"><a class="back-bib" href="#back-bib45">45</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Lamprecht</span> <span
            class="ja50-ce-given-name">M</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Bogner</span> <span class="ja50-ce-given-name">S</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Schippinger</span> <span
            class="ja50-ce-given-name">G</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Int Soc Sports Nutr</span></span> <span
                class="ja50-sb-date">2012</span>; <span
                class="ja50-sb-volume-nr">9</span>: </span><span
                class="ja50-sb-pages">45</span>. </span></div>
    <div class="refshow" id="bib46"><a class="back-bib" href="#back-bib46">46</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Xiao</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Fei</span> <span
            class="ja50-ce-given-name">N</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Pang</span> <span class="ja50-ce-given-name">X</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">FEMS Microbiol Ecol</span></span> <span
                class="ja50-sb-date">2014</span>; <span class="ja50-sb-volume-nr">87</span>: </span><span
                class="ja50-sb-pages">357-367</span>. </span></div>
    <div class="refshow" id="bib47"><a class="back-bib" href="#back-bib47">47</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Hamer</span> <span class="ja50-ce-given-name">HM</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Jonkers</span> <span
            class="ja50-ce-given-name">D</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Venema</span> <span class="ja50-ce-given-name">K</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Vanhoutvin</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Troost</span> <span
            class="ja50-ce-given-name">FJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Brummer</span> <span class="ja50-ce-given-name">RJ</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Review article: the role of butyrate on colonic function</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Aliment Pharmacol Ther</span></span> <span
                class="ja50-sb-date">2008</span>; <span class="ja50-sb-volume-nr">27</span>: </span><span
                class="ja50-sb-pages">104-119</span>. </span></div>
    <div class="refshow" id="bib48"><a class="back-bib" href="#back-bib48">48</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Topping</span> <span
            class="ja50-ce-given-name">DL</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Clifton</span> <span class="ja50-ce-given-name">PM</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Short-chain fatty acids and human colonic function: roles of resistant starch and non-starch polysaccharides</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Physiol Rev</span></span> <span
                class="ja50-sb-date">2001</span>; <span class="ja50-sb-volume-nr">81</span>: </span><span
                class="ja50-sb-pages">1031-1064</span>. </span></div>
    <div class="refshow" id="bib49"><a class="back-bib" href="#back-bib49">49</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ohata</span> <span
            class="ja50-ce-given-name">A</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Usami</span> <span
            class="ja50-ce-given-name">M</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Miyoshi</span> <span class="ja50-ce-given-name">M</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Nutrition</span></span> <span
                class="ja50-sb-date">2005</span>; <span class="ja50-sb-volume-nr">21</span>: </span><span
                class="ja50-sb-pages">838-847</span>. </span></div>
    <div class="refshow" id="bib50"><a class="back-bib" href="#back-bib50">50</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Peng</span> <span
            class="ja50-ce-given-name">L</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">He</span> <span
            class="ja50-ce-given-name">Z</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Chen</span> <span
            class="ja50-ce-given-name">W</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Holzman</span> <span
            class="ja50-ce-given-name">IR</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Lin</span> <span
            class="ja50-ce-given-name">J</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Pediatr Res</span></span> <span
                class="ja50-sb-date">2007</span>; <span class="ja50-sb-volume-nr">61</span>: </span><span
                class="ja50-sb-pages">37-41</span>. </span></div>
    <div class="refshow" id="bib51"><a class="back-bib" href="#back-bib51">51</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Siavoshian</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Segain</span> <span
            class="ja50-ce-given-name">JP</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kornprobst</span> <span
            class="ja50-ce-given-name">M</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Gut</span></span> <span class="ja50-sb-date">2000</span>; <span
                class="ja50-sb-volume-nr">46</span>: </span><span
                class="ja50-sb-pages">507-514</span>. </span></div>
    <div class="refshow" id="bib52"><a class="back-bib" href="#back-bib52">52</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Tang</span> <span
            class="ja50-ce-given-name">Y</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Chen</span> <span
            class="ja50-ce-given-name">Y</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Jiang</span> <span
            class="ja50-ce-given-name">H</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Nie</span> <span
            class="ja50-ce-given-name">D</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Cell Death Differ</span></span> <span
                class="ja50-sb-date">2011</span>; <span class="ja50-sb-volume-nr">18</span>: </span><span
                class="ja50-sb-pages">602-618</span>. </span></div>
    <div class="refshow" id="bib53"><a class="back-bib" href="#back-bib53">53</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Suzuki</span> <span class="ja50-ce-given-name">T</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Yoshida</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Hara</span> <span
            class="ja50-ce-given-name">H</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Br J Nutr</span></span> <span
                class="ja50-sb-date">2008</span>; <span
                class="ja50-sb-volume-nr">100</span>: </span><span
                class="ja50-sb-pages">297-305</span>. </span></div>
    <div class="refshow" id="bib54"><a class="back-bib" href="#back-bib54">54</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Donohoe</span> <span
            class="ja50-ce-given-name">DR</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Garge</span> <span
            class="ja50-ce-given-name">N</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Zhang</span> <span class="ja50-ce-given-name">X</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Cell Metab</span></span> <span
                class="ja50-sb-date">2011</span>; <span class="ja50-sb-volume-nr">13</span>: </span><span
                class="ja50-sb-pages">517-526</span>. </span></div>
    <div class="refshow" id="bib55"><a class="back-bib" href="#back-bib55">55</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Nofrarias</span> <span
            class="ja50-ce-given-name">M</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Martinez-Puig</span> <span class="ja50-ce-given-name">D</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Pujols</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Majo</span> <span
            class="ja50-ce-given-name">N</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Perez</span> <span
            class="ja50-ce-given-name">JF</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Long-term intake of resistant starch improves colonic mucosal integrity and reduces gut apoptosis and blood immune cells</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Nutrition</span></span> <span
                class="ja50-sb-date">2007</span>; <span class="ja50-sb-volume-nr">23</span>: </span><span
                class="ja50-sb-pages">861-870</span>. </span></div>
    <div class="refshow" id="bib56"><a class="back-bib" href="#back-bib56">56</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Breuer</span> <span
            class="ja50-ce-given-name">RI</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Soergel</span> <span
            class="ja50-ce-given-name">KH</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Lashner</span> <span class="ja50-ce-given-name">BA</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Gut</span></span> <span class="ja50-sb-date">1997</span>; <span
                class="ja50-sb-volume-nr">40</span>: </span><span
                class="ja50-sb-pages">485-491</span>. </span></div>
    <div class="refshow" id="bib57"><a class="back-bib" href="#back-bib57">57</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Walton</span> <span
            class="ja50-ce-given-name">GE</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Lu</span> <span
            class="ja50-ce-given-name">C</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Trogh</span> <span
            class="ja50-ce-given-name">I</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Arnaut</span> <span class="ja50-ce-given-name">F</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Gibson</span> <span
            class="ja50-ce-given-name">GR</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Nutr J</span></span> <span
                class="ja50-sb-date">2012</span>; <span class="ja50-sb-volume-nr">11</span>: </span><span
                class="ja50-sb-pages">36</span>. </span></div>
    <div class="refshow" id="bib58"><a class="back-bib" href="#back-bib58">58</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">West</span> <span
            class="ja50-ce-given-name">NP</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Christophersen</span> <span class="ja50-ce-given-name">CT</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Pyne</span> <span
            class="ja50-ce-given-name">DB</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Butyrylated starch increases colonic butyrate concentration but has limited effects on immunity in healthy physically active individuals</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Exerc Immunol Rev</span></span> <span
                class="ja50-sb-date">2013</span>; <span class="ja50-sb-volume-nr">19</span>: </span><span
                class="ja50-sb-pages">102-119</span>. </span></div>
    <div class="refshow" id="bib59"><a class="back-bib" href="#back-bib59">59</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Covington</span> <span
            class="ja50-ce-given-name">DK</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Briscoe</span> <span
            class="ja50-ce-given-name">CA</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Brown</span> <span class="ja50-ce-given-name">AJ</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Jayawickreme</span> <span
            class="ja50-ce-given-name">CK</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Biochem Soc Trans</span></span> <span
                class="ja50-sb-date">2006</span>; <span class="ja50-sb-volume-nr">34</span>: </span><span
                class="ja50-sb-pages">770-773</span>. </span></div>
    <div class="refshow" id="bib60"><a class="back-bib" href="#back-bib60">60</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Le Poul</span> <span
            class="ja50-ce-given-name">E</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Loison</span> <span class="ja50-ce-given-name">C</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Struyf</span> <span
            class="ja50-ce-given-name">S</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Biol Chem</span></span> <span
                class="ja50-sb-date">2003</span>; <span
                class="ja50-sb-volume-nr">278</span>: </span><span
                class="ja50-sb-pages">25481-25489</span>. </span></div>
    <div class="refshow" id="bib61"><a class="back-bib" href="#back-bib61">61</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Vinolo</span> <span
            class="ja50-ce-given-name">MA</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Rodrigues</span> <span
            class="ja50-ce-given-name">HG</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Nachbar</span> <span
            class="ja50-ce-given-name">RT</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Curi</span> <span
            class="ja50-ce-given-name">R</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Regulation of inflammation by short chain fatty acids</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Nutrients</span></span> <span
                class="ja50-sb-date">2011</span>; <span
                class="ja50-sb-volume-nr">3</span>: </span><span
                class="ja50-sb-pages">858-876</span>. </span></div>
    <div class="refshow" id="bib62"><a class="back-bib" href="#back-bib62">62</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kim</span> <span
            class="ja50-ce-given-name">MH</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kang</span> <span
            class="ja50-ce-given-name">SG</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Park</span> <span
            class="ja50-ce-given-name">JH</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Yanagisawa</span> <span
            class="ja50-ce-given-name">M</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kim</span> <span
            class="ja50-ce-given-name">CH</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Gastroenterology</span></span> <span class="ja50-sb-date">2013</span>; <span
                class="ja50-sb-volume-nr">145</span>: </span><span
                class="ja50-sb-pages">396-406</span>. </span></div>
    <div class="refshow" id="bib63"><a class="back-bib" href="#back-bib63">63</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Sina</span> <span
            class="ja50-ce-given-name">C</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Gavrilova</span> <span
            class="ja50-ce-given-name">O</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Forster</span> <span class="ja50-ce-given-name">M</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Immunol</span></span> <span
                class="ja50-sb-date">2009</span>; <span
                class="ja50-sb-volume-nr">183</span>: </span><span
                class="ja50-sb-pages">7514-7522</span>. </span></div>
    <div class="refshow" id="bib64"><a class="back-bib" href="#back-bib64">64</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Maslowski</span> <span
            class="ja50-ce-given-name">KM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Vieira</span> <span
            class="ja50-ce-given-name">AT</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ng</span> <span class="ja50-ce-given-name">A</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Nature</span></span> <span
                class="ja50-sb-date">2009</span>; <span
                class="ja50-sb-volume-nr">461</span>: </span><span
                class="ja50-sb-pages">1282-1286</span>. </span></div>
    <div class="refshow" id="bib65"><a class="back-bib" href="#back-bib65">65</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Furusawa</span> <span
            class="ja50-ce-given-name">Y</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Obata</span> <span
            class="ja50-ce-given-name">Y</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Fukuda</span> <span class="ja50-ce-given-name">S</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Nature</span></span> <span
                class="ja50-sb-date">2013</span>; <span
                class="ja50-sb-volume-nr">504</span>: </span><span
                class="ja50-sb-pages">446-450</span>. </span></div>
    <div class="refshow" id="bib66"><a class="back-bib" href="#back-bib66">66</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Smith</span> <span class="ja50-ce-given-name">PM</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Howitt</span> <span
            class="ja50-ce-given-name">MR</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Panikov</span> <span class="ja50-ce-given-name">N</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Science</span></span> <span
                class="ja50-sb-date">2013</span>; <span
                class="ja50-sb-volume-nr">341</span>: </span><span
                class="ja50-sb-pages">569-573</span>. </span></div>
    <div class="refshow" id="bib67"><a class="back-bib" href="#back-bib67">67</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Cools</span> <span
            class="ja50-ce-given-name">N</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ponsaerts</span> <span
            class="ja50-ce-given-name">P</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Van Tendeloo</span> <span class="ja50-ce-given-name">VF</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Berneman</span> <span
            class="ja50-ce-given-name">ZN</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Regulatory T cells and human disease</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Clin Dev Immunol</span></span> <span class="ja50-sb-date">2007</span>; <span
                class="ja50-sb-volume-nr">2007</span>: </span><span
                class="ja50-sb-pages">89195</span>. </span></div>
    <div class="refshow" id="bib68"><a class="back-bib" href="#back-bib68">68</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Konieczna</span> <span
            class="ja50-ce-given-name">P</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Groeger</span> <span
            class="ja50-ce-given-name">D</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ziegler</span> <span class="ja50-ce-given-name">M</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle"><i>Bifidobacterium infantis</i> 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Gut</span></span> <span class="ja50-sb-date">2012</span>; <span
                class="ja50-sb-volume-nr">61</span>: </span><span
                class="ja50-sb-pages">354-366</span>. </span></div>
    <div class="refshow" id="bib69"><a class="back-bib" href="#back-bib69">69</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Harris</span> <span class="ja50-ce-given-name">K</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Kassis</span> <span
            class="ja50-ce-given-name">A</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Major</span> <span
            class="ja50-ce-given-name">G</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Chou</span> <span
            class="ja50-ce-given-name">CJ</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Is the gut microbiota a new factor contributing to obesity and its metabolic disorders?</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Obes</span></span> <span
                class="ja50-sb-date">2012</span>; <span
                class="ja50-sb-volume-nr">2012</span>: </span><span
                class="ja50-sb-pages">879151</span>. </span></div>
    <div class="refshow" id="bib70"><a class="back-bib" href="#back-bib70">70</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Laugerette</span> <span
            class="ja50-ce-given-name">F</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Vors</span> <span
            class="ja50-ce-given-name">C</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Geloen</span> <span class="ja50-ce-given-name">A</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Nutr Biochem</span></span> <span class="ja50-sb-date">2011</span>; <span
                class="ja50-sb-volume-nr">22</span>: </span><span class="ja50-sb-pages">53-59</span>. </span>
    </div>
    <div class="refshow" id="bib71"><a class="back-bib" href="#back-bib71">71</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ghoshal</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Witta</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Zhong</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">de Villiers</span> <span
            class="ja50-ce-given-name">W</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Eckhardt</span> <span class="ja50-ce-given-name">E</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Chylomicrons promote intestinal absorption of lipopolysaccharides</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Lipid Res</span></span> <span
                class="ja50-sb-date">2009</span>; <span class="ja50-sb-volume-nr">50</span>: </span><span
                class="ja50-sb-pages">90-97</span>. </span></div>
    <div class="refshow" id="bib72"><a class="back-bib" href="#back-bib72">72</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Amar</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Burcelin</span> <span
            class="ja50-ce-given-name">R</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ruidavets</span> <span
            class="ja50-ce-given-name">JB</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Energy intake is associated with endotoxemia in apparently healthy men</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Am J Clin Nutr</span></span> <span class="ja50-sb-date">2008</span>; <span
                class="ja50-sb-volume-nr">87</span>: </span><span
                class="ja50-sb-pages">1219-1223</span>. </span></div>
    <div class="refshow" id="bib73"><a class="back-bib" href="#back-bib73">73</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Cani</span> <span
            class="ja50-ce-given-name">PD</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Bibiloni</span> <span
            class="ja50-ce-given-name">R</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Knauf</span> <span class="ja50-ce-given-name">C</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Diabetes</span></span> <span
                class="ja50-sb-date">2008</span>; <span class="ja50-sb-volume-nr">57</span>: </span><span
                class="ja50-sb-pages">1470-1481</span>. </span></div>
    <div class="refshow" id="bib74"><a class="back-bib" href="#back-bib74">74</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Pendyala</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Walker</span> <span
            class="ja50-ce-given-name">JM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Holt</span> <span
            class="ja50-ce-given-name">PR</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">A high-fat diet is associated with endotoxemia that originates from the gut</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Gastroenterology</span></span> <span class="ja50-sb-date">2012</span>; <span
                class="ja50-sb-volume-nr">142</span>: </span><span
                class="ja50-sb-pages">1100-1101</span>. </span></div>
    <div class="refshow" id="bib75"><a class="back-bib" href="#back-bib75">75</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ghanim</span> <span class="ja50-ce-given-name">H</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Abuaysheh</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Sia</span> <span class="ja50-ce-given-name">CL</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Diabetes Care</span></span> <span class="ja50-sb-date">2009</span>; <span
                class="ja50-sb-volume-nr">32</span>: </span><span
                class="ja50-sb-pages">2281-2287</span>. </span></div>
    <div class="refshow" id="bib76"><a class="back-bib" href="#back-bib76">76</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ghanim</span> <span class="ja50-ce-given-name">H</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Sia</span> <span
            class="ja50-ce-given-name">CL</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Upadhyay</span> <span class="ja50-ce-given-name">M</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Am J Clin Nutr</span></span> <span class="ja50-sb-date">2010</span>; <span
                class="ja50-sb-volume-nr">91</span>: </span><span
                class="ja50-sb-pages">940-949</span>. </span></div>
    <div class="refshow" id="bib77"><a class="back-bib" href="#back-bib77">77</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Erridge</span> <span
            class="ja50-ce-given-name">C</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Attina</span> <span class="ja50-ce-given-name">T</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Spickett</span> <span
            class="ja50-ce-given-name">CM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Webb</span> <span
            class="ja50-ce-given-name">DJ</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Am J Clin Nutr</span></span> <span class="ja50-sb-date">2007</span>; <span
                class="ja50-sb-volume-nr">86</span>: </span><span
                class="ja50-sb-pages">1286-1292</span>. </span></div>
    <div class="refshow" id="bib78"><a class="back-bib" href="#back-bib78">78</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Manco</span> <span
            class="ja50-ce-given-name">M</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Putignani</span> <span
            class="ja50-ce-given-name">L</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Bottazzo</span> <span
            class="ja50-ce-given-name">GF</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Endocr Rev</span></span> <span
                class="ja50-sb-date">2010</span>; <span class="ja50-sb-volume-nr">31</span>: </span><span
                class="ja50-sb-pages">817-844</span>. </span></div>
    <div class="refshow" id="bib79"><a class="back-bib" href="#back-bib79">79</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Neves</span> <span class="ja50-ce-given-name">AL</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Coelho</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Couto</span> <span
            class="ja50-ce-given-name">L</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Leite-Moreira</span> <span class="ja50-ce-given-name">A</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Roncon-Albuquerque</span> <span
            class="ja50-ce-given-name">R</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Mol Endocrinol</span></span> <span class="ja50-sb-date">2013</span>; <span
                class="ja50-sb-volume-nr">51</span>: </span><span
                class="ja50-sb-pages">R51-R64</span>. </span></div>
    <div class="refshow" id="bib80"><a class="back-bib" href="#back-bib80">80</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Wiedermann</span> <span
            class="ja50-ce-given-name">CJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kiechl</span> <span class="ja50-ce-given-name">S</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Dunzendorfer</span> <span
            class="ja50-ce-given-name">S</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Am Coll Cardiol</span></span> <span
                class="ja50-sb-date">1999</span>; <span class="ja50-sb-volume-nr">34</span>: </span><span
                class="ja50-sb-pages">1975-1981</span>. </span></div>
    <div class="refshow" id="bib81"><a class="back-bib" href="#back-bib81">81</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Pussinen</span> <span
            class="ja50-ce-given-name">PJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Tuomisto</span> <span
            class="ja50-ce-given-name">K</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Jousilahti</span> <span
            class="ja50-ce-given-name">P</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Havulinna</span> <span
            class="ja50-ce-given-name">AS</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Sundvall</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Salomaa</span> <span class="ja50-ce-given-name">V</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Arterioscler Thromb Vasc Biol</span></span> <span
                class="ja50-sb-date">2007</span>; <span class="ja50-sb-volume-nr">27</span>: </span><span
                class="ja50-sb-pages">1433-1439</span>. </span></div>
    <div class="refshow" id="bib82"><a class="back-bib" href="#back-bib82">82</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Creely</span> <span
            class="ja50-ce-given-name">SJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">McTernan</span> <span
            class="ja50-ce-given-name">PG</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kusminski</span> <span
            class="ja50-ce-given-name">CM</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Am J Physiol Endocrinol Metab</span></span> <span
                class="ja50-sb-date">2007</span>; <span
                class="ja50-sb-volume-nr">292</span>: </span><span
                class="ja50-sb-pages">E740-E747</span>. </span></div>
    <div class="refshow" id="bib83"><a class="back-bib" href="#back-bib83">83</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Al-Attas</span> <span
            class="ja50-ce-given-name">OS</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Al-Daghri</span> <span
            class="ja50-ce-given-name">NM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Al-Rubeaan</span> <span
            class="ja50-ce-given-name">K</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Cardiovasc Diabetol</span></span> <span
                class="ja50-sb-date">2009</span>; <span
                class="ja50-sb-volume-nr">8</span>: </span><span
                class="ja50-sb-pages">20</span>. </span></div>
    <div class="refshow" id="bib84"><a class="back-bib" href="#back-bib84">84</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Pussinen</span> <span
            class="ja50-ce-given-name">PJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Havulinna</span> <span
            class="ja50-ce-given-name">AS</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Lehto</span> <span
            class="ja50-ce-given-name">M</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Sundvall</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Salomaa</span> <span class="ja50-ce-given-name">V</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Endotoxemia is associated with an increased risk of incident diabetes</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Diabetes Care</span></span> <span class="ja50-sb-date">2011</span>; <span
                class="ja50-sb-volume-nr">34</span>: </span><span
                class="ja50-sb-pages">392-397</span>. </span></div>
    <div class="refshow" id="bib85"><a class="back-bib" href="#back-bib85">85</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Zweigner</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Schumann</span> <span
            class="ja50-ce-given-name">RR</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Weber</span> <span
            class="ja50-ce-given-name">JR</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">The role of lipopolysaccharide-binding protein in modulating the innate immune response</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Microbes Infect</span></span> <span class="ja50-sb-date">2006</span>; <span
                class="ja50-sb-volume-nr">8</span>: </span><span
                class="ja50-sb-pages">946-952</span>. </span></div>
    <div class="refshow" id="bib86"><a class="back-bib" href="#back-bib86">86</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Levels</span> <span
            class="ja50-ce-given-name">JH</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Abraham</span> <span
            class="ja50-ce-given-name">PR</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">van den Ende</span> <span class="ja50-ce-given-name">A</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">van Deventer</span> <span
            class="ja50-ce-given-name">SJ</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Distribution and kinetics of lipoprotein-bound endotoxin</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Infect Immun</span></span> <span
                class="ja50-sb-date">2001</span>; <span class="ja50-sb-volume-nr">69</span>: </span><span
                class="ja50-sb-pages">2821-2828</span>. </span></div>
    <div class="refshow" id="bib87"><a class="back-bib" href="#back-bib87">87</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Zweigner</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Gramm</span> <span class="ja50-ce-given-name">HJ</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Singer</span> <span
            class="ja50-ce-given-name">OC</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Wegscheider</span> <span
            class="ja50-ce-given-name">K</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Schumann</span> <span
            class="ja50-ce-given-name">RR</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Blood</span></span> <span class="ja50-sb-date">2001</span>; <span
                class="ja50-sb-volume-nr">98</span>: </span><span
                class="ja50-sb-pages">3800-3808</span>. </span></div>
    <div class="refshow" id="bib88"><a class="back-bib" href="#back-bib88">88</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Blairon</span> <span
            class="ja50-ce-given-name">L</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Wittebole</span> <span
            class="ja50-ce-given-name">X</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Laterre</span> <span class="ja50-ce-given-name">PF</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Infect Dis</span></span> <span
                class="ja50-sb-date">2003</span>; <span
                class="ja50-sb-volume-nr">187</span>: </span><span
                class="ja50-sb-pages">287-291</span>. </span></div>
    <div class="refshow" id="bib89"><a class="back-bib" href="#back-bib89">89</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Gonzalez-Quintela</span> <span
            class="ja50-ce-given-name">A</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Alonso</span> <span class="ja50-ce-given-name">M</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Campos</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Vizcaino</span> <span
            class="ja50-ce-given-name">L</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Loidi</span> <span
            class="ja50-ce-given-name">L</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Gude</span> <span
            class="ja50-ce-given-name">F</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">PLoS One</span></span> <span
                class="ja50-sb-date">2013</span>; <span
                class="ja50-sb-volume-nr">8</span>: </span><span class="ja50-sb-pages">e54600</span>. </span>
    </div>
    <div class="refshow" id="bib90"><a class="back-bib" href="#back-bib90">90</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Moreno-Navarrete</span> <span
            class="ja50-ce-given-name">JM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Ortega</span> <span class="ja50-ce-given-name">F</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Serino</span> <span
            class="ja50-ce-given-name">M</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Int J Obes</span></span> <span
                class="ja50-sb-date">2012</span>; <span class="ja50-sb-volume-nr">36</span>: </span><span
                class="ja50-sb-pages">1442-1449</span>. </span></div>
    <div class="refshow" id="bib91"><a class="back-bib" href="#back-bib91">91</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Qian</span> <span
            class="ja50-ce-given-name">C</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Cao</span> <span
            class="ja50-ce-given-name">X</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Regulation of Toll-like receptor signaling pathways in innate immune responses</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Ann N Y Acad Sci</span></span> <span class="ja50-sb-date">2013</span>; <span
                class="ja50-sb-volume-nr">1283</span>: </span><span
                class="ja50-sb-pages">67-74</span>. </span></div>
    <div class="refshow" id="bib92"><a class="back-bib" href="#back-bib92">92</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kim</span> <span
            class="ja50-ce-given-name">JJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Sears</span> <span
            class="ja50-ce-given-name">DD</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">TLR4 and insulin resistance</span></span></span>. <span
            class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Gastroenterol Res Pract</span></span> <span
            class="ja50-sb-date">2010</span>; <span
            class="ja50-sb-volume-nr">2010</span>: </span><span class="ja50-sb-pages">212563</span>. </span>
    </div>
    <div class="refshow" id="bib93"><a class="back-bib" href="#back-bib93">93</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Anand</span> <span class="ja50-ce-given-name">RJ</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Kohler</span> <span
            class="ja50-ce-given-name">JW</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Cavallo</span> <span
            class="ja50-ce-given-name">JA</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Li</span> <span
            class="ja50-ce-given-name">J</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Dubowski</span> <span
            class="ja50-ce-given-name">T</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Hackam</span> <span class="ja50-ce-given-name">DJ</span></span></span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Toll-like receptor 4 plays a role in macrophage phagocytosis during peritoneal sepsis</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Pediatr Surg</span></span> <span class="ja50-sb-date">2007</span>; <span
                class="ja50-sb-volume-nr">42</span>: </span><span
                class="ja50-sb-pages">927-932</span>. </span></div>
    <div class="refshow" id="bib94"><a class="back-bib" href="#back-bib94">94</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Gosemann</span> <span
            class="ja50-ce-given-name">JH</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">van Griensven</span> <span class="ja50-ce-given-name">M</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Barkhausen</span> <span
            class="ja50-ce-given-name">T</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">TLR4 influences the humoral and cellular immune response during polymicrobial sepsis</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Injury</span></span> <span
                class="ja50-sb-date">2010</span>; <span class="ja50-sb-volume-nr">41</span>: </span><span
                class="ja50-sb-pages">1060-1067</span>. </span></div>
    <div class="refshow" id="bib95"><a class="back-bib" href="#back-bib95">95</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Verbon</span> <span class="ja50-ce-given-name">A</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Dekkers</span> <span
            class="ja50-ce-given-name">PE</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">ten Hove</span> <span class="ja50-ce-given-name">T</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Immunol</span></span> <span
                class="ja50-sb-date">2001</span>; <span
                class="ja50-sb-volume-nr">166</span>: </span><span
                class="ja50-sb-pages">3599-3605</span>. </span></div>
    <div class="refshow" id="bib96"><a class="back-bib" href="#back-bib96">96</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Olszyna</span> <span
            class="ja50-ce-given-name">DP</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Verbon</span> <span class="ja50-ce-given-name">A</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Pribble</span> <span
            class="ja50-ce-given-name">JP</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Effect of IC14, an anti-CD14 antibody, on plasma and cell-associated chemokines during human endotoxemia</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Eur Cytokine Netw</span></span> <span
                class="ja50-sb-date">2003</span>; <span class="ja50-sb-volume-nr">14</span>: </span><span
                class="ja50-sb-pages">158-162</span>. </span></div>
    <div class="refshow" id="bib97"><a class="back-bib" href="#back-bib97">97</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Song</span> <span
            class="ja50-ce-given-name">MJ</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kim</span> <span
            class="ja50-ce-given-name">KH</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Yoon</span> <span
            class="ja50-ce-given-name">JM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Kim</span> <span
            class="ja50-ce-given-name">JB</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Biochem Biophys Res Commun</span></span> <span
                class="ja50-sb-date">2006</span>; <span
                class="ja50-sb-volume-nr">346</span>: </span><span
                class="ja50-sb-pages">739-745</span>. </span></div>
    <div class="refshow" id="bib98"><a class="back-bib" href="#back-bib98">98</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Tsukumo</span> <span
            class="ja50-ce-given-name">DM</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Carvalho-Filho</span> <span class="ja50-ce-given-name">MA</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Carvalheira</span> <span
            class="ja50-ce-given-name">JB</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Diabetes</span></span> <span
                class="ja50-sb-date">2007</span>; <span class="ja50-sb-volume-nr">56</span>: </span><span
                class="ja50-sb-pages">1986-1998</span>. </span></div>
    <div class="refshow" id="bib99"><a class="back-bib" href="#back-bib99">99</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Michelsen</span> <span
            class="ja50-ce-given-name">KS</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Wong</span> <span
            class="ja50-ce-given-name">MH</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Shah</span> <span class="ja50-ce-given-name">PK</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Proc Natl Acad Sci USA</span></span> <span
                class="ja50-sb-date">2004</span>; <span
                class="ja50-sb-volume-nr">101</span>: </span><span
                class="ja50-sb-pages">10679-10684</span>. </span></div>
    <div class="refshow" id="bib100"><a class="back-bib" href="#back-bib100">100</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Li</span> <span
            class="ja50-ce-given-name">Q</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Zhang</span> <span
            class="ja50-ce-given-name">Q</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Wang</span> <span
            class="ja50-ce-given-name">C</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Liu</span> <span
            class="ja50-ce-given-name">X</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Li</span> <span
            class="ja50-ce-given-name">N</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Li</span> <span
            class="ja50-ce-given-name">J</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Disruption of tight junctions during polymicrobial sepsis in vivo</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Pathol</span></span> <span
                class="ja50-sb-date">2009</span>; <span
                class="ja50-sb-volume-nr">218</span>: </span><span
                class="ja50-sb-pages">210-221</span>. </span></div>
    <div class="refshow" id="bib101"><a class="back-bib" href="#back-bib101">101</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Lai</span> <span
            class="ja50-ce-given-name">CW</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Sun</span> <span
            class="ja50-ce-given-name">TL</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Lo</span> <span class="ja50-ce-given-name">W</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Shedding-induced gap formation contributes to gut barrier dysfunction in endotoxemia</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Trauma Acute Care Surg</span></span> <span
                class="ja50-sb-date">2013</span>; <span class="ja50-sb-volume-nr">74</span>: </span><span
                class="ja50-sb-pages">203-213</span>. </span></div>
    <div class="refshow" id="bib102"><a class="back-bib" href="#back-bib102">102</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Jorgensen</span> <span
            class="ja50-ce-given-name">VL</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Nielsen</span> <span
            class="ja50-ce-given-name">SL</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Espersen</span> <span
            class="ja50-ce-given-name">K</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Perner</span> <span
            class="ja50-ce-given-name">A</span></span></span>. <span class="ja50-sb-title"><span
            class="ja50-sb-maintitle">Increased colorectal permeability in patients with severe sepsis and septic shock</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Intensive Care Med</span></span> <span
                class="ja50-sb-date">2006</span>; <span class="ja50-sb-volume-nr">32</span>: </span><span
                class="ja50-sb-pages">1790-1796</span>. </span></div>
    <div class="refshow" id="bib103"><a class="back-bib" href="#back-bib103">103</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Hietbrink</span> <span
            class="ja50-ce-given-name">F</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Besselink</span> <span
            class="ja50-ce-given-name">MG</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Renooij</span> <span class="ja50-ce-given-name">W</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Systemic inflammation increases intestinal permeability during experimental human endotoxemia</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Shock</span></span> <span class="ja50-sb-date">2009</span>; <span
                class="ja50-sb-volume-nr">32</span>: </span><span
                class="ja50-sb-pages">374-378</span>. </span></div>
    <div class="refshow" id="bib104"><a class="back-bib" href="#back-bib104">104</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Klaus</span> <span class="ja50-ce-given-name">DA</span>, </span><span
            class="ja50-sb-author"><span class="ja50-ce-surname">Motal</span> <span
            class="ja50-ce-given-name">MC</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Burger-Klepp</span> <span
            class="ja50-ce-given-name">U</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Increased plasma zonulin in patients with sepsis</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Biochem Med</span></span> <span
                class="ja50-sb-date">2013</span>; <span class="ja50-sb-volume-nr">23</span>: </span><span
                class="ja50-sb-pages">107-111</span>. </span></div>
    <div class="refshow" id="bib105"><a class="back-bib" href="#back-bib105">105</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Cani</span> <span
            class="ja50-ce-given-name">PD</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Possemiers</span> <span
            class="ja50-ce-given-name">S</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Van de Wiele</span> <span
            class="ja50-ce-given-name">T</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">Gut</span></span> <span class="ja50-sb-date">2009</span>; <span
                class="ja50-sb-volume-nr">58</span>: </span><span
                class="ja50-sb-pages">1091-1103</span>. </span></div>
    <div class="refshow" id="bib106"><a class="back-bib" href="#back-bib106">106</a> <span
            class="ja50-sb-contribution"><span class="ja50-sb-authors"><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Naito</span> <span
            class="ja50-ce-given-name">E</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Yoshida</span> <span
            class="ja50-ce-given-name">Y</span>, </span><span class="ja50-sb-author"><span
            class="ja50-ce-surname">Makino</span> <span class="ja50-ce-given-name">K</span></span>, et al</span>. <span
            class="ja50-sb-title"><span class="ja50-sb-maintitle">Beneficial effect of oral administration of <i>Lactobacillus
        casei</i> strain Shirota on insulin resistance in diet-induced obesity mice</span></span></span>.
        <span class="ja50-sb-host"><span class="ja50-sb-issue"><span class="ja50-sb-title"><span
                class="ja50-sb-maintitle">J Appl Microbiol</span></span> <span class="ja50-sb-date">2011</span>; <span
                class="ja50-sb-volume-nr">110</span>: </span><span
                class="ja50-sb-pages">650-657</span>. </span></div>
</div>
<div class="bibMultiContainer" id="bibMultiContainer">
    <div id="bibMulti2" class="ref1"></div>
</div>
<div id="front-matter" class="fm">
    ©
    2015 Elsevier Ltd. All rights reserved.<br/>S2213-8587(14)70134-2 - see front matter <br/>DOI:
    10.1016/S2213-8587(14)70134-2
</div>
<script src="../../js/style.js" type="text/javascript"></script>
<script src="../../../notes_js/custom.js"></script>
</body>
</html>
